Gene Symbol | Gene ID | Gene Info |
---|---|---|
Chd1
|
ENSMUSG00000023852.7 | chromodomain helicase DNA binding protein 1 |
Pml
|
ENSMUSG00000036986.10 | promyelocytic leukemia |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr17_15690458_15690609 | Chd1 | 14434 | 0.181255 | 0.39 | 2.9e-03 | Click! |
chr17_15704306_15705493 | Chd1 | 68 | 0.976152 | 0.28 | 3.6e-02 | Click! |
chr17_15701706_15701857 | Chd1 | 3186 | 0.259753 | 0.28 | 4.1e-02 | Click! |
chr17_15701500_15701651 | Chd1 | 3392 | 0.252571 | 0.21 | 1.2e-01 | Click! |
chr17_15774943_15775094 | Chd1 | 18253 | 0.162228 | 0.19 | 1.5e-01 | Click! |
chr9_58229170_58229321 | Pml | 882 | 0.433971 | 0.26 | 5.3e-02 | Click! |
chr9_58228931_58229082 | Pml | 1121 | 0.343097 | 0.26 | 5.3e-02 | Click! |
chr9_58232484_58232635 | Pml | 826 | 0.466558 | 0.24 | 7.2e-02 | Click! |
chr9_58247520_58247704 | Pml | 2011 | 0.212705 | 0.19 | 1.7e-01 | Click! |
chr9_58246140_58246457 | Pml | 3325 | 0.152414 | 0.14 | 3.1e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_174329445_174331091 | 20.00 |
Gnas |
GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus |
19 |
0.97 |
chr17_34898151_34899707 | 15.65 |
Ehmt2 |
euchromatic histone lysine N-methyltransferase 2 |
25 |
0.87 |
chrX_142680720_142682167 | 13.93 |
Tmem164 |
transmembrane protein 164 |
25 |
0.98 |
chr19_41482494_41483686 | 13.46 |
Lcor |
ligand dependent nuclear receptor corepressor |
61 |
0.98 |
chr11_102316544_102317735 | 13.43 |
Ubtf |
upstream binding transcription factor, RNA polymerase I |
148 |
0.92 |
chr15_98608664_98610204 | 11.91 |
Adcy6 |
adenylate cyclase 6 |
598 |
0.55 |
chr17_88065293_88066116 | 10.85 |
Fbxo11 |
F-box protein 11 |
413 |
0.86 |
chr11_88068171_88069196 | 10.53 |
Vezf1 |
vascular endothelial zinc finger 1 |
404 |
0.76 |
chr2_48949106_48950119 | 10.08 |
Mbd5 |
methyl-CpG binding domain protein 5 |
89 |
0.8 |
chr13_55210517_55212032 | 9.72 |
Nsd1 |
nuclear receptor-binding SET-domain protein 1 |
267 |
0.89 |
chr4_140701770_140702866 | 9.71 |
Rcc2 |
regulator of chromosome condensation 2 |
845 |
0.47 |
chr2_106692893_106694599 | 9.55 |
Mpped2 |
metallophosphoesterase domain containing 2 |
477 |
0.85 |
chr17_28800512_28801462 | 9.35 |
Brpf3 |
bromodomain and PHD finger containing, 3 |
103 |
0.88 |
chr10_80150235_80151164 | 9.09 |
Midn |
midnolin |
242 |
0.82 |
chr11_77607040_77608322 | 9.06 |
Taok1 |
TAO kinase 1 |
134 |
0.94 |
chr3_51340298_51341882 | 8.63 |
Elf2 |
E74-like factor 2 |
427 |
0.74 |
chr9_44881205_44881917 | 8.46 |
Gm39326 |
predicted gene, 39326 |
167 |
0.6 |
chr5_143731658_143732384 | 8.41 |
Usp42 |
ubiquitin specific peptidase 42 |
259 |
0.91 |
chr5_121545189_121545856 | 8.26 |
Adam1a |
a disintegrin and metallopeptidase domain 1a |
40 |
0.44 |
chr15_81585272_81586453 | 8.22 |
Gm23880 |
predicted gene, 23880 |
271 |
0.52 |
chr8_70698268_70700333 | 8.07 |
Jund |
jun D proto-oncogene |
351 |
0.45 |
chr15_102470670_102471447 | 8.06 |
Pcbp2 |
poly(rC) binding protein 2 |
10 |
0.95 |
chr5_43232754_43234178 | 8.00 |
Cpeb2 |
cytoplasmic polyadenylation element binding protein 2 |
296 |
0.85 |
chr10_7955532_7956133 | 7.99 |
Tab2 |
TGF-beta activated kinase 1/MAP3K7 binding protein 2 |
61 |
0.98 |
chr5_149051995_149052486 | 7.99 |
Hmgb1 |
high mobility group box 1 |
137 |
0.93 |
chr1_9784412_9784711 | 7.91 |
1700034P13Rik |
RIKEN cDNA 1700034P13 gene |
783 |
0.55 |
chr6_72898945_72900607 | 7.89 |
Kcmf1 |
potassium channel modulatory factor 1 |
73 |
0.97 |
chr15_96286955_96287696 | 7.86 |
Arid2 |
AT rich interactive domain 2 (ARID, RFX-like) |
193 |
0.94 |
chr8_54076785_54077878 | 7.80 |
Vegfc |
vascular endothelial growth factor C |
275 |
0.95 |
chr14_25606696_25608421 | 7.59 |
Zmiz1 |
zinc finger, MIZ-type containing 1 |
201 |
0.95 |
chr6_140623130_140624606 | 7.56 |
Aebp2 |
AE binding protein 2 |
179 |
0.93 |
chr1_134559997_134561478 | 7.52 |
Kdm5b |
lysine (K)-specific demethylase 5B |
530 |
0.69 |
chr7_36697059_36698174 | 7.41 |
Tshz3 |
teashirt zinc finger family member 3 |
502 |
0.7 |
chr17_30004516_30005139 | 7.39 |
Zfand3 |
zinc finger, AN1-type domain 3 |
94 |
0.55 |
chr11_87986817_87988025 | 7.38 |
Dynll2 |
dynein light chain LC8-type 2 |
65 |
0.96 |
chr14_20793233_20794132 | 7.37 |
Camk2g |
calcium/calmodulin-dependent protein kinase II gamma |
284 |
0.68 |
chr5_22344110_22345571 | 7.28 |
Reln |
reelin |
138 |
0.95 |
chr16_30063252_30064537 | 7.27 |
Hes1 |
hes family bHLH transcription factor 1 |
490 |
0.76 |
chr7_127026546_127028177 | 7.21 |
Maz |
MYC-associated zinc finger protein (purine-binding transcription factor) |
324 |
0.58 |
chr2_170130477_170131578 | 7.17 |
Zfp217 |
zinc finger protein 217 |
193 |
0.97 |
chr1_181211252_181211896 | 7.04 |
Wdr26 |
WD repeat domain 26 |
137 |
0.94 |
chr4_138216258_138217700 | 6.98 |
Hp1bp3 |
heterochromatin protein 1, binding protein 3 |
148 |
0.91 |
chr13_34344501_34346084 | 6.98 |
Slc22a23 |
solute carrier family 22, member 23 |
110 |
0.97 |
chr13_45963809_45964773 | 6.97 |
Atxn1 |
ataxin 1 |
666 |
0.54 |
chr13_63564531_63566515 | 6.96 |
Ptch1 |
patched 1 |
212 |
0.91 |
chr9_65826224_65827697 | 6.96 |
Zfp609 |
zinc finger protein 609 |
604 |
0.65 |
chrX_104200417_104201582 | 6.95 |
Nexmif |
neurite extension and migration factor |
118 |
0.97 |
chr9_57644752_57646108 | 6.88 |
Csk |
c-src tyrosine kinase |
187 |
0.91 |
chr5_122501856_122502977 | 6.83 |
Atp2a2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
191 |
0.88 |
chr12_51828795_51830087 | 6.72 |
Hectd1 |
HECT domain E3 ubiquitin protein ligase 1 |
95 |
0.97 |
chr16_56075244_56076135 | 6.72 |
Senp7 |
SUMO1/sentrin specific peptidase 7 |
209 |
0.9 |
chr2_51946774_51947120 | 6.69 |
Nmi |
N-myc (and STAT) interactor |
5630 |
0.18 |
chr17_47923769_47925323 | 6.60 |
Foxp4 |
forkhead box P4 |
70 |
0.96 |
chr9_109094576_109096217 | 6.59 |
Plxnb1 |
plexin B1 |
7 |
0.95 |
chr8_120486990_120488549 | 6.58 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
678 |
0.64 |
chr17_46555466_46556535 | 6.50 |
Srf |
serum response factor |
175 |
0.9 |
chr19_3767273_3768554 | 6.45 |
Kmt5b |
lysine methyltransferase 5B |
120 |
0.93 |
chr2_118901578_118902232 | 6.42 |
Bahd1 |
bromo adjacent homology domain containing 1 |
452 |
0.76 |
chrX_51204673_51205680 | 6.39 |
Mbnl3 |
muscleblind like splicing factor 3 |
656 |
0.65 |
chr10_26374889_26375811 | 6.38 |
L3mbtl3 |
L3MBTL3 histone methyl-lysine binding protein |
165 |
0.94 |
chr1_166002288_166003185 | 6.37 |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
58 |
0.72 |
chr10_80576603_80578409 | 6.31 |
Klf16 |
Kruppel-like factor 16 |
185 |
0.86 |
chr12_52503984_52504723 | 6.30 |
Arhgap5 |
Rho GTPase activating protein 5 |
11 |
0.98 |
chr13_43480925_43481874 | 6.26 |
Ranbp9 |
RAN binding protein 9 |
117 |
0.95 |
chr17_15375662_15377138 | 6.24 |
Dll1 |
delta like canonical Notch ligand 1 |
424 |
0.8 |
chr3_136669841_136670888 | 6.22 |
Ppp3ca |
protein phosphatase 3, catalytic subunit, alpha isoform |
240 |
0.94 |
chrX_42067696_42069057 | 6.16 |
Xiap |
X-linked inhibitor of apoptosis |
22 |
0.98 |
chr15_36793516_36794080 | 6.16 |
Ywhaz |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide |
39 |
0.97 |
chr11_3289074_3290615 | 6.11 |
Patz1 |
POZ (BTB) and AT hook containing zinc finger 1 |
149 |
0.93 |
chr4_88032518_88033581 | 6.10 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
232 |
0.71 |
chr4_131873537_131874159 | 6.09 |
Srsf4 |
serine and arginine-rich splicing factor 4 |
32 |
0.96 |
chr18_82692173_82693291 | 5.95 |
Zfp236 |
zinc finger protein 236 |
2 |
0.86 |
chr4_53439670_53441073 | 5.94 |
Slc44a1 |
solute carrier family 44, member 1 |
42 |
0.98 |
chr5_21055259_21056077 | 5.88 |
Ptpn12 |
protein tyrosine phosphatase, non-receptor type 12 |
57 |
0.97 |
chr11_60104775_60106860 | 5.85 |
Rai1 |
retinoic acid induced 1 |
640 |
0.67 |
chr17_53566897_53568169 | 5.83 |
Kat2b |
K(lysine) acetyltransferase 2B |
562 |
0.71 |
chr11_32455251_32455991 | 5.81 |
Ubtd2 |
ubiquitin domain containing 2 |
251 |
0.93 |
chr9_101073622_101074688 | 5.78 |
Msl2 |
MSL complex subunit 2 |
54 |
0.96 |
chr7_25686729_25687529 | 5.76 |
Tgfb1 |
transforming growth factor, beta 1 |
127 |
0.91 |
chr17_37045564_37046927 | 5.75 |
Gabbr1 |
gamma-aminobutyric acid (GABA) B receptor, 1 |
46 |
0.94 |
chr11_94327762_94328694 | 5.74 |
Ankrd40 |
ankyrin repeat domain 40 |
26 |
0.97 |
chr11_69096542_69097348 | 5.69 |
Per1 |
period circadian clock 1 |
1728 |
0.15 |
chr16_94570319_94571250 | 5.61 |
Dyrk1a |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1a |
80 |
0.97 |
chr11_98795502_98796538 | 5.58 |
Msl1 |
male specific lethal 1 |
220 |
0.87 |
chr17_45685681_45686990 | 5.56 |
Mrpl14 |
mitochondrial ribosomal protein L14 |
13 |
0.54 |
chr13_111686492_111687222 | 5.53 |
Mier3 |
MIER family member 3 |
45 |
0.97 |
chr7_28179836_28180482 | 5.52 |
Dyrk1b |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1b |
107 |
0.93 |
chr15_79690079_79691459 | 5.52 |
Gtpbp1 |
GTP binding protein 1 |
76 |
0.92 |
chr4_33923766_33925291 | 5.50 |
Cnr1 |
cannabinoid receptor 1 (brain) |
65 |
0.98 |
chr14_49172432_49173089 | 5.43 |
Naa30 |
N(alpha)-acetyltransferase 30, NatC catalytic subunit |
162 |
0.95 |
chr1_63113503_63114557 | 5.42 |
Ino80dos |
INO80 complex subunit D, opposite strand |
66 |
0.7 |
chr17_78199734_78201570 | 5.38 |
Crim1 |
cysteine rich transmembrane BMP regulator 1 (chordin like) |
267 |
0.74 |
chr18_21299601_21300892 | 5.38 |
Garem1 |
GRB2 associated regulator of MAPK1 subtype 1 |
108 |
0.96 |
chr3_84814728_84815427 | 5.33 |
Fbxw7 |
F-box and WD-40 domain protein 7 |
191 |
0.96 |
chr3_103914017_103915242 | 5.32 |
Rsbn1 |
rosbin, round spermatid basic protein 1 |
62 |
0.95 |
chr16_91824601_91824806 | 5.30 |
Itsn1 |
intersectin 1 (SH3 domain protein 1A) |
2834 |
0.25 |
chr1_86525613_86527056 | 5.27 |
Ptma |
prothymosin alpha |
392 |
0.81 |
chr1_160906609_160907194 | 5.27 |
Rc3h1 |
RING CCCH (C3H) domains 1 |
483 |
0.62 |
chr1_87326740_87327750 | 5.20 |
Gigyf2 |
GRB10 interacting GYF protein 2 |
179 |
0.92 |
chr2_72979541_72979824 | 5.18 |
Sp3os |
trans-acting transcription factor 3, opposite strand |
166 |
0.74 |
chr9_35116070_35117303 | 5.14 |
4930581F22Rik |
RIKEN cDNA 4930581F22 gene |
42 |
0.69 |
chr2_154790876_154791702 | 5.13 |
Raly |
hnRNP-associated with lethal yellow |
63 |
0.56 |
chr6_125095392_125097556 | 5.11 |
Chd4 |
chromodomain helicase DNA binding protein 4 |
95 |
0.84 |
chr9_115309763_115310685 | 5.11 |
Stt3b |
STT3, subunit of the oligosaccharyltransferase complex, homolog B (S. cerevisiae) |
197 |
0.94 |
chr3_100488535_100489982 | 5.11 |
Tent5c |
terminal nucleotidyltransferase 5C |
60 |
0.85 |
chr11_85139345_85140659 | 5.10 |
Usp32 |
ubiquitin specific peptidase 32 |
34 |
0.97 |
chr6_53067832_53069023 | 5.10 |
Jazf1 |
JAZF zinc finger 1 |
204 |
0.95 |
chr11_77983926_77984968 | 5.10 |
Phf12 |
PHD finger protein 12 |
1645 |
0.25 |
chr11_115419815_115420841 | 5.09 |
Kctd2 |
potassium channel tetramerisation domain containing 2 |
16 |
0.83 |
chr16_31663986_31664463 | 5.08 |
Dlg1 |
discs large MAGUK scaffold protein 1 |
74 |
0.97 |
chr11_98741567_98742727 | 5.07 |
Thra |
thyroid hormone receptor alpha |
11 |
0.95 |
chr18_39489335_39489856 | 5.06 |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
251 |
0.95 |
chr19_29251015_29252343 | 5.06 |
Jak2 |
Janus kinase 2 |
149 |
0.96 |
chr7_118243052_118244285 | 5.03 |
Smg1 |
SMG1 homolog, phosphatidylinositol 3-kinase-related kinase (C. elegans) |
2 |
0.72 |
chr12_111039101_111039789 | 5.02 |
Rcor1 |
REST corepressor 1 |
94 |
0.95 |
chr6_4902832_4903901 | 5.00 |
Ppp1r9a |
protein phosphatase 1, regulatory subunit 9A |
7 |
0.97 |
chr2_92183514_92184054 | 5.00 |
Phf21a |
PHD finger protein 21A |
322 |
0.88 |
chr3_30507827_30509444 | 4.99 |
Mecom |
MDS1 and EVI1 complex locus |
852 |
0.52 |
chr17_34592277_34593459 | 4.96 |
Pbx2 |
pre B cell leukemia homeobox 2 |
134 |
0.85 |
chr17_63498782_63499619 | 4.96 |
Fbxl17 |
F-box and leucine-rich repeat protein 17 |
817 |
0.71 |
chr18_24259035_24259422 | 4.96 |
Gm7701 |
predicted gene 7701 |
1850 |
0.37 |
chr17_3114762_3115867 | 4.89 |
Scaf8 |
SR-related CTD-associated factor 8 |
65 |
0.87 |
chr6_4600437_4601751 | 4.89 |
Casd1 |
CAS1 domain containing 1 |
52 |
0.96 |
chr11_23255157_23256431 | 4.85 |
Xpo1 |
exportin 1 |
247 |
0.94 |
chr2_60209324_60210635 | 4.85 |
Marchf7 |
membrane associated ring-CH-type finger 7 |
66 |
0.6 |
chr8_88199683_88200218 | 4.84 |
Tent4b |
terminal nucleotidyltransferase 4B |
736 |
0.61 |
chr3_135438626_135439246 | 4.82 |
Ube2d3 |
ubiquitin-conjugating enzyme E2D 3 |
72 |
0.74 |
chr9_21615608_21616677 | 4.82 |
Smarca4 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
27 |
0.95 |
chr12_76709620_76710348 | 4.80 |
Sptb |
spectrin beta, erythrocytic |
39 |
0.98 |
chr5_118560415_118560665 | 4.80 |
Med13l |
mediator complex subunit 13-like |
139 |
0.95 |
chr4_46450476_46451941 | 4.78 |
Anp32b |
acidic (leucine-rich) nuclear phosphoprotein 32 family, member B |
306 |
0.86 |
chr2_167688815_167689311 | 4.78 |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
148 |
0.86 |
chr7_100607194_100608447 | 4.77 |
Rab6a |
RAB6A, member RAS oncogene family |
130 |
0.55 |
chr7_25249061_25250506 | 4.74 |
Erf |
Ets2 repressor factor |
947 |
0.33 |
chr6_124919273_124920636 | 4.73 |
Ptms |
parathymosin |
149 |
0.88 |
chr2_60880792_60881813 | 4.73 |
Rbms1 |
RNA binding motif, single stranded interacting protein 1 |
136 |
0.98 |
chr19_12794683_12795497 | 4.72 |
Zfp91 |
zinc finger protein 91 |
1036 |
0.3 |
chr17_34024565_34026019 | 4.71 |
Mir219a-1 |
microRNA 219a-1 |
200 |
0.34 |
chr6_83456116_83457458 | 4.71 |
Tet3 |
tet methylcytosine dioxygenase 3 |
395 |
0.77 |
chr2_104816068_104817467 | 4.70 |
Qser1 |
glutamine and serine rich 1 |
7 |
0.97 |
chr2_75659366_75659972 | 4.70 |
Hnrnpa3 |
heterogeneous nuclear ribonucleoprotein A3 |
351 |
0.52 |
chr11_117968531_117970182 | 4.69 |
Socs3 |
suppressor of cytokine signaling 3 |
95 |
0.96 |
chr11_12036502_12038049 | 4.68 |
Grb10 |
growth factor receptor bound protein 10 |
126 |
0.97 |
chr11_107131631_107132030 | 4.67 |
Bptf |
bromodomain PHD finger transcription factor |
92 |
0.96 |
chr4_101355840_101357064 | 4.66 |
E130102H24Rik |
RIKEN cDNA E130102H24 gene |
204 |
0.88 |
chr11_102393202_102394154 | 4.63 |
Rundc3a |
RUN domain containing 3A |
275 |
0.82 |
chr16_35983144_35984124 | 4.61 |
Kpna1 |
karyopherin (importin) alpha 1 |
52 |
0.85 |
chr6_7844118_7845326 | 4.61 |
C1galt1 |
core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1 |
120 |
0.95 |
chr15_91049248_91050457 | 4.61 |
Kif21a |
kinesin family member 21A |
7 |
0.98 |
chr10_126978694_126979699 | 4.60 |
Ctdsp2 |
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 2 |
167 |
0.89 |
chr10_117845199_117845877 | 4.58 |
Rap1b |
RAS related protein 1b |
497 |
0.74 |
chr11_3202493_3203344 | 4.58 |
Eif4enif1 |
eukaryotic translation initiation factor 4E nuclear import factor 1 |
77 |
0.95 |
chr11_101467552_101468698 | 4.56 |
Rnd2 |
Rho family GTPase 2 |
50 |
0.92 |
chr13_42051896_42052956 | 4.56 |
Hivep1 |
human immunodeficiency virus type I enhancer binding protein 1 |
22 |
0.98 |
chr12_118301013_118301849 | 4.55 |
Sp4 |
trans-acting transcription factor 4 |
9 |
0.99 |
chrX_71556134_71556919 | 4.55 |
Hmgb3 |
high mobility group box 3 |
420 |
0.84 |
chr3_52985507_52985880 | 4.55 |
Cog6 |
component of oligomeric golgi complex 6 |
8992 |
0.16 |
chr4_133752707_133753245 | 4.55 |
Arid1a |
AT rich interactive domain 1A (SWI-like) |
635 |
0.66 |
chr2_32712708_32713229 | 4.54 |
Mir3960 |
microRNA 3960 |
4 |
0.4 |
chr2_60124621_60125204 | 4.54 |
Gm13620 |
predicted gene 13620 |
184 |
0.84 |
chr15_98762205_98763035 | 4.53 |
Arf3 |
ADP-ribosylation factor 3 |
372 |
0.74 |
chr10_127288807_127289691 | 4.53 |
Mbd6 |
methyl-CpG binding domain protein 6 |
231 |
0.7 |
chr13_51792800_51793928 | 4.53 |
Sema4d |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
300 |
0.91 |
chr17_28232452_28233404 | 4.53 |
Ppard |
peroxisome proliferator activator receptor delta |
121 |
0.93 |
chr12_101028530_101029714 | 4.52 |
Ccdc88c |
coiled-coil domain containing 88C |
66 |
0.95 |
chr2_93013668_93015442 | 4.51 |
Prdm11 |
PR domain containing 11 |
645 |
0.73 |
chr19_27216773_27217950 | 4.50 |
Vldlr |
very low density lipoprotein receptor |
4 |
0.98 |
chr19_53329198_53330470 | 4.48 |
Mxi1 |
MAX interactor 1, dimerization protein |
26 |
0.97 |
chr3_22076598_22077433 | 4.47 |
Tbl1xr1 |
transducin (beta)-like 1X-linked receptor 1 |
79 |
0.93 |
chr15_6708302_6709258 | 4.46 |
Rictor |
RPTOR independent companion of MTOR, complex 2 |
397 |
0.87 |
chr1_64532608_64533440 | 4.46 |
Creb1 |
cAMP responsive element binding protein 1 |
130 |
0.97 |
chr19_42147565_42148817 | 4.43 |
Marveld1 |
MARVEL (membrane-associating) domain containing 1 |
483 |
0.69 |
chr3_90265231_90266258 | 4.42 |
Dennd4b |
DENN/MADD domain containing 4B |
559 |
0.53 |
chr10_42761629_42762453 | 4.42 |
Sec63 |
SEC63-like (S. cerevisiae) |
235 |
0.91 |
chr10_40349107_40350122 | 4.42 |
Cdk19 |
cyclin-dependent kinase 19 |
88 |
0.86 |
chr2_5951282_5952030 | 4.40 |
Upf2 |
UPF2 regulator of nonsense transcripts homolog (yeast) |
187 |
0.94 |
chr4_127021472_127021942 | 4.38 |
Sfpq |
splicing factor proline/glutamine rich (polypyrimidine tract binding protein associated) |
383 |
0.77 |
chr11_70844543_70845547 | 4.37 |
Rabep1 |
rabaptin, RAB GTPase binding effector protein 1 |
70 |
0.95 |
chr16_32643757_32644967 | 4.32 |
Tnk2 |
tyrosine kinase, non-receptor, 2 |
71 |
0.96 |
chr4_133753861_133754198 | 4.29 |
Arid1a |
AT rich interactive domain 1A (SWI-like) |
47 |
0.97 |
chr9_63757305_63758776 | 4.27 |
Smad3 |
SMAD family member 3 |
46 |
0.98 |
chr11_69367990_69369160 | 4.26 |
Chd3 |
chromodomain helicase DNA binding protein 3 |
816 |
0.37 |
chr1_106171607_106172350 | 4.25 |
Phlpp1 |
PH domain and leucine rich repeat protein phosphatase 1 |
226 |
0.72 |
chr6_28832054_28833275 | 4.24 |
Lrrc4 |
leucine rich repeat containing 4 |
917 |
0.59 |
chr10_43479277_43480054 | 4.24 |
Bend3 |
BEN domain containing 3 |
525 |
0.71 |
chr8_104395019_104396337 | 4.23 |
Cmtm4 |
CKLF-like MARVEL transmembrane domain containing 4 |
129 |
0.93 |
chr16_44139601_44140743 | 4.23 |
Naa50 |
N(alpha)-acetyltransferase 50, NatE catalytic subunit |
280 |
0.66 |
chr5_96162084_96163134 | 4.23 |
Cnot6l |
CCR4-NOT transcription complex, subunit 6-like |
619 |
0.75 |
chr2_168206505_168207218 | 4.21 |
Adnp |
activity-dependent neuroprotective protein |
61 |
0.95 |
chr2_126674783_126675421 | 4.20 |
Gabpb1 |
GA repeat binding protein, beta 1 |
237 |
0.82 |
chr6_122339632_122340371 | 4.19 |
Phc1 |
polyhomeotic 1 |
223 |
0.9 |
chr19_38836411_38837637 | 4.19 |
Tbc1d12 |
TBC1D12: TBC1 domain family, member 12 |
347 |
0.88 |
chr14_62760761_62761843 | 4.18 |
Ints6 |
integrator complex subunit 6 |
133 |
0.95 |
chr11_5740506_5741309 | 4.18 |
Urgcp |
upregulator of cell proliferation |
239 |
0.89 |
chr2_153528510_153529333 | 4.17 |
Nol4l |
nucleolar protein 4-like |
1050 |
0.54 |
chr1_59762633_59764016 | 4.17 |
Bmpr2 |
bone morphogenetic protein receptor, type II (serine/threonine kinase) |
76 |
0.96 |
chr6_39206608_39207344 | 4.17 |
Gm49041 |
predicted gene, 49041 |
92 |
0.63 |
chr6_120037782_120038258 | 4.16 |
Wnk1 |
WNK lysine deficient protein kinase 1 |
361 |
0.85 |
chr11_119040519_119041332 | 4.13 |
Cbx8 |
chromobox 8 |
14 |
0.97 |
chr17_83214679_83215981 | 4.12 |
Pkdcc |
protein kinase domain containing, cytoplasmic |
38 |
0.98 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.5 | 19.5 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
5.0 | 20.2 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
4.8 | 19.1 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
4.7 | 14.2 | GO:0036166 | phenotypic switching(GO:0036166) |
4.7 | 14.0 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
4.4 | 13.3 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
4.3 | 12.8 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
4.2 | 16.8 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
4.0 | 12.0 | GO:0045608 | negative regulation of auditory receptor cell differentiation(GO:0045608) |
3.6 | 14.4 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
3.2 | 9.7 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
3.1 | 15.6 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
2.9 | 11.7 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
2.9 | 8.8 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
2.9 | 17.4 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
2.9 | 11.6 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
2.9 | 11.5 | GO:0007296 | vitellogenesis(GO:0007296) |
2.8 | 11.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
2.8 | 8.3 | GO:0045472 | response to ether(GO:0045472) |
2.7 | 8.1 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
2.7 | 8.1 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
2.7 | 10.7 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
2.6 | 7.9 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
2.6 | 10.5 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
2.6 | 7.9 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
2.6 | 10.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
2.5 | 7.6 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
2.4 | 7.3 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
2.4 | 7.3 | GO:0008050 | female courtship behavior(GO:0008050) |
2.4 | 14.5 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
2.4 | 7.2 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
2.4 | 9.4 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
2.3 | 18.7 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
2.3 | 2.3 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
2.3 | 2.3 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
2.3 | 22.7 | GO:0031507 | heterochromatin assembly(GO:0031507) |
2.2 | 6.7 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
2.2 | 17.8 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
2.2 | 4.4 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
2.2 | 8.7 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
2.2 | 10.8 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
2.1 | 10.7 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
2.1 | 8.5 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
2.1 | 6.3 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
2.1 | 14.4 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
2.0 | 14.3 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
2.0 | 6.0 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
2.0 | 5.9 | GO:0061010 | gall bladder development(GO:0061010) |
2.0 | 5.9 | GO:0002432 | granuloma formation(GO:0002432) |
1.9 | 17.4 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
1.9 | 3.8 | GO:0070375 | ERK5 cascade(GO:0070375) |
1.9 | 15.0 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
1.8 | 7.4 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
1.8 | 7.3 | GO:0070828 | heterochromatin organization(GO:0070828) |
1.8 | 1.8 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) positive regulation of histone deacetylase activity(GO:1901727) |
1.8 | 19.9 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
1.8 | 7.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
1.8 | 7.2 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
1.8 | 8.9 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
1.8 | 12.3 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
1.7 | 3.5 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
1.7 | 5.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
1.7 | 6.8 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
1.7 | 8.4 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
1.7 | 6.7 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
1.7 | 3.3 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.6 | 4.9 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
1.6 | 9.7 | GO:0015871 | choline transport(GO:0015871) |
1.6 | 3.2 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
1.6 | 3.2 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
1.6 | 4.8 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
1.6 | 4.8 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
1.6 | 4.7 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
1.6 | 4.7 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
1.6 | 9.4 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
1.6 | 4.7 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
1.5 | 4.6 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
1.5 | 10.8 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
1.5 | 4.6 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
1.5 | 1.5 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
1.5 | 4.6 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
1.5 | 3.0 | GO:0032776 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
1.5 | 6.1 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
1.5 | 4.5 | GO:0032439 | endosome localization(GO:0032439) |
1.5 | 4.5 | GO:0006543 | glutamine catabolic process(GO:0006543) |
1.5 | 4.5 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.5 | 4.5 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
1.5 | 11.8 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
1.4 | 7.2 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
1.4 | 4.3 | GO:1903286 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
1.4 | 11.4 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
1.4 | 2.8 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
1.4 | 4.2 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.4 | 4.2 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
1.4 | 8.4 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
1.4 | 4.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.4 | 5.6 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
1.4 | 23.5 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
1.4 | 2.8 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
1.4 | 5.5 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
1.4 | 22.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
1.4 | 4.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.4 | 5.4 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
1.4 | 1.4 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
1.4 | 6.8 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
1.4 | 4.1 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
1.4 | 4.1 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
1.3 | 2.7 | GO:0035973 | aggrephagy(GO:0035973) |
1.3 | 8.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
1.3 | 8.0 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
1.3 | 4.0 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
1.3 | 4.0 | GO:0060789 | hair follicle placode formation(GO:0060789) |
1.3 | 3.9 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
1.3 | 10.5 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) |
1.3 | 1.3 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
1.3 | 5.2 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
1.3 | 11.7 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
1.3 | 3.9 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
1.3 | 2.6 | GO:0021553 | olfactory nerve development(GO:0021553) |
1.3 | 6.4 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
1.3 | 2.5 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
1.3 | 6.3 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
1.3 | 12.7 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
1.3 | 25.2 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
1.2 | 3.7 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
1.2 | 1.2 | GO:0036394 | amylase secretion(GO:0036394) |
1.2 | 5.0 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
1.2 | 3.6 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
1.2 | 9.7 | GO:0043249 | erythrocyte maturation(GO:0043249) |
1.2 | 14.4 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
1.2 | 3.6 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
1.2 | 2.4 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
1.2 | 2.4 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.2 | 2.4 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
1.2 | 4.8 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
1.2 | 9.5 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
1.2 | 5.9 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
1.2 | 7.1 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
1.2 | 3.6 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
1.2 | 1.2 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
1.2 | 1.2 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
1.2 | 7.0 | GO:0016266 | O-glycan processing(GO:0016266) |
1.2 | 1.2 | GO:0003383 | apical constriction(GO:0003383) |
1.2 | 10.5 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
1.2 | 4.6 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
1.2 | 8.1 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
1.2 | 1.2 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
1.1 | 2.3 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
1.1 | 3.4 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
1.1 | 8.0 | GO:0001842 | neural fold formation(GO:0001842) |
1.1 | 2.3 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
1.1 | 7.9 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
1.1 | 4.5 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
1.1 | 2.2 | GO:1902414 | protein localization to cell junction(GO:1902414) |
1.1 | 3.3 | GO:0090148 | membrane fission(GO:0090148) |
1.1 | 2.2 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
1.1 | 4.4 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
1.1 | 5.5 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
1.1 | 1.1 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
1.1 | 4.3 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
1.1 | 2.2 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
1.1 | 1.1 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
1.1 | 4.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
1.1 | 2.1 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
1.1 | 2.1 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
1.1 | 7.5 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
1.1 | 3.2 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
1.1 | 2.1 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
1.1 | 5.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
1.1 | 7.4 | GO:1901660 | calcium ion export(GO:1901660) |
1.1 | 1.1 | GO:1902488 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
1.1 | 2.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
1.1 | 9.5 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
1.0 | 1.0 | GO:0009211 | pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) |
1.0 | 3.1 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
1.0 | 3.1 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
1.0 | 5.2 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
1.0 | 5.2 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
1.0 | 3.1 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
1.0 | 3.1 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
1.0 | 4.1 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
1.0 | 3.0 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
1.0 | 3.0 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
1.0 | 15.1 | GO:0016574 | histone ubiquitination(GO:0016574) |
1.0 | 3.0 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
1.0 | 3.0 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
1.0 | 2.0 | GO:0048382 | mesendoderm development(GO:0048382) |
1.0 | 5.9 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
1.0 | 4.9 | GO:0072553 | terminal button organization(GO:0072553) |
1.0 | 12.8 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
1.0 | 9.8 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
1.0 | 2.9 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
1.0 | 5.9 | GO:2000489 | hepatic stellate cell activation(GO:0035733) regulation of hepatic stellate cell activation(GO:2000489) |
1.0 | 2.0 | GO:0031053 | primary miRNA processing(GO:0031053) |
1.0 | 1.0 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
1.0 | 3.9 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
1.0 | 6.7 | GO:0060613 | fat pad development(GO:0060613) |
1.0 | 1.0 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
1.0 | 5.7 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
1.0 | 2.9 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
1.0 | 4.8 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.9 | 3.8 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.9 | 1.9 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.9 | 1.9 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.9 | 3.7 | GO:0080009 | mRNA methylation(GO:0080009) |
0.9 | 1.9 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.9 | 5.6 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.9 | 2.8 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.9 | 2.8 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.9 | 2.8 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.9 | 3.7 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.9 | 38.7 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.9 | 5.5 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.9 | 5.5 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.9 | 2.7 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.9 | 4.6 | GO:0060770 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.9 | 11.8 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.9 | 4.5 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.9 | 1.8 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.9 | 1.8 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.9 | 8.1 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.9 | 3.6 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.9 | 2.7 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.9 | 4.5 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.9 | 3.6 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.9 | 7.2 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.9 | 3.6 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.9 | 2.7 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.9 | 0.9 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.9 | 2.7 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.9 | 2.7 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.9 | 1.8 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.9 | 4.4 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.9 | 1.8 | GO:2000591 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.9 | 0.9 | GO:0060214 | endocardium formation(GO:0060214) |
0.9 | 1.7 | GO:0060956 | endocardial cell differentiation(GO:0060956) |
0.9 | 2.6 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.9 | 0.9 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.9 | 4.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.9 | 2.6 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.8 | 3.4 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.8 | 5.1 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.8 | 4.2 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.8 | 2.5 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
0.8 | 2.5 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.8 | 0.8 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.8 | 2.5 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.8 | 5.9 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.8 | 1.7 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.8 | 3.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.8 | 2.5 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
0.8 | 0.8 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.8 | 4.9 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.8 | 1.6 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.8 | 20.4 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.8 | 7.3 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.8 | 2.4 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.8 | 6.5 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.8 | 3.2 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.8 | 4.8 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.8 | 6.4 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.8 | 0.8 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.8 | 6.3 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.8 | 1.6 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.8 | 2.4 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.8 | 1.6 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.8 | 3.9 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
0.8 | 0.8 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.8 | 2.3 | GO:0000087 | mitotic M phase(GO:0000087) |
0.8 | 9.3 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.8 | 2.3 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.8 | 2.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.8 | 3.9 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.8 | 3.9 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.8 | 2.3 | GO:0072718 | response to cisplatin(GO:0072718) |
0.8 | 1.5 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.8 | 2.3 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.8 | 3.8 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.8 | 0.8 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.8 | 4.6 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.8 | 2.3 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.8 | 3.0 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.8 | 1.5 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.8 | 3.0 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.8 | 4.5 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.8 | 0.8 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.8 | 3.0 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.8 | 3.0 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.7 | 6.7 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.7 | 4.5 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.7 | 1.5 | GO:0072537 | fibroblast activation(GO:0072537) |
0.7 | 2.2 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.7 | 3.7 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.7 | 3.7 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.7 | 2.2 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.7 | 0.7 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.7 | 3.6 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.7 | 2.1 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.7 | 0.7 | GO:0042023 | DNA endoreduplication(GO:0042023) |
0.7 | 4.3 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.7 | 2.1 | GO:0030242 | pexophagy(GO:0030242) |
0.7 | 2.1 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.7 | 19.5 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.7 | 1.4 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.7 | 1.4 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.7 | 0.7 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.7 | 1.4 | GO:1903273 | regulation of sodium ion export(GO:1903273) regulation of sodium ion export from cell(GO:1903276) |
0.7 | 3.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.7 | 4.8 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.7 | 1.4 | GO:1902075 | cellular response to salt(GO:1902075) |
0.7 | 2.8 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.7 | 2.1 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.7 | 1.4 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.7 | 6.8 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.7 | 2.0 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.7 | 2.0 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.7 | 0.7 | GO:0039535 | regulation of RIG-I signaling pathway(GO:0039535) |
0.7 | 0.7 | GO:0061724 | lipophagy(GO:0061724) |
0.7 | 0.7 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.7 | 1.3 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.7 | 6.0 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.7 | 0.7 | GO:1901033 | positive regulation of response to reactive oxygen species(GO:1901033) |
0.7 | 0.7 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.7 | 2.7 | GO:1902893 | regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902893) positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.7 | 12.6 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.7 | 2.0 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.7 | 5.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.7 | 1.3 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
0.7 | 0.7 | GO:2001273 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.7 | 2.6 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.7 | 11.8 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.7 | 3.3 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.6 | 6.5 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.6 | 1.3 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.6 | 2.6 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.6 | 2.6 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.6 | 0.6 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.6 | 0.6 | GO:0071335 | hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) |
0.6 | 1.3 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.6 | 1.9 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.6 | 0.6 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.6 | 1.9 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.6 | 3.2 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.6 | 0.6 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.6 | 3.8 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.6 | 0.6 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.6 | 2.5 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.6 | 1.9 | GO:0050686 | negative regulation of mRNA processing(GO:0050686) |
0.6 | 1.3 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.6 | 5.7 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
0.6 | 3.8 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.6 | 4.4 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.6 | 2.5 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.6 | 2.5 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.6 | 1.9 | GO:0048069 | eye pigmentation(GO:0048069) |
0.6 | 1.9 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.6 | 2.5 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.6 | 0.6 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.6 | 5.0 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.6 | 1.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.6 | 4.4 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.6 | 1.3 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.6 | 1.9 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.6 | 2.5 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.6 | 1.2 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.6 | 0.6 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.6 | 6.2 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.6 | 1.9 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.6 | 1.2 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.6 | 1.2 | GO:0052203 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.6 | 2.5 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.6 | 1.2 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.6 | 1.8 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.6 | 11.1 | GO:0031648 | protein destabilization(GO:0031648) |
0.6 | 1.8 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.6 | 4.3 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.6 | 3.1 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.6 | 1.2 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.6 | 4.3 | GO:0051352 | negative regulation of ligase activity(GO:0051352) |
0.6 | 20.1 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.6 | 4.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.6 | 1.8 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.6 | 4.9 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.6 | 7.3 | GO:0045116 | protein neddylation(GO:0045116) |
0.6 | 1.2 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.6 | 1.2 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.6 | 1.2 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
0.6 | 8.5 | GO:0044783 | mitotic G1 DNA damage checkpoint(GO:0031571) G1 DNA damage checkpoint(GO:0044783) |
0.6 | 3.0 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.6 | 7.2 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
0.6 | 12.6 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.6 | 4.2 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.6 | 1.8 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.6 | 1.2 | GO:0044838 | cell quiescence(GO:0044838) |
0.6 | 0.6 | GO:1903312 | negative regulation of mRNA metabolic process(GO:1903312) |
0.6 | 4.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.6 | 1.2 | GO:0045991 | carbon catabolite activation of transcription(GO:0045991) |
0.6 | 1.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.6 | 1.2 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.6 | 5.9 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.6 | 1.8 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.6 | 0.6 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.6 | 2.9 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.6 | 1.8 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.6 | 17.6 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.6 | 2.3 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.6 | 1.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.6 | 1.8 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.6 | 12.9 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.6 | 1.8 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.6 | 1.8 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.6 | 3.5 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.6 | 0.6 | GO:0061082 | myeloid leukocyte cytokine production(GO:0061082) |
0.6 | 3.5 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.6 | 1.7 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.6 | 2.3 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.6 | 1.7 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.6 | 0.6 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.6 | 1.7 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.6 | 1.7 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.6 | 1.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.6 | 2.9 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.6 | 1.7 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.6 | 4.0 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.6 | 3.4 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.6 | 1.7 | GO:0042938 | dipeptide transport(GO:0042938) |
0.6 | 0.6 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.6 | 6.2 | GO:0043486 | histone exchange(GO:0043486) |
0.6 | 1.7 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.6 | 1.1 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.6 | 3.9 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.6 | 1.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.6 | 7.7 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.5 | 2.2 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.5 | 2.2 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.5 | 1.6 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.5 | 2.7 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.5 | 0.5 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.5 | 1.6 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.5 | 1.1 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.5 | 0.5 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.5 | 0.5 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.5 | 4.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.5 | 1.1 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.5 | 5.9 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.5 | 1.1 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.5 | 1.6 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.5 | 3.2 | GO:0006477 | protein sulfation(GO:0006477) |
0.5 | 2.1 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.5 | 2.7 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.5 | 2.7 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.5 | 5.8 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.5 | 1.1 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.5 | 3.2 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.5 | 1.6 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.5 | 1.1 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.5 | 2.6 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.5 | 1.6 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.5 | 1.6 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.5 | 2.1 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.5 | 2.6 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.5 | 1.0 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.5 | 8.4 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.5 | 0.5 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.5 | 2.1 | GO:0008228 | opsonization(GO:0008228) |
0.5 | 3.7 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.5 | 1.6 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.5 | 0.5 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.5 | 2.1 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
0.5 | 1.0 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.5 | 0.5 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.5 | 2.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.5 | 2.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.5 | 3.1 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.5 | 1.5 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.5 | 1.0 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.5 | 0.5 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.5 | 0.5 | GO:0036120 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.5 | 3.1 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.5 | 1.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.5 | 2.0 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.5 | 2.6 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.5 | 3.6 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.5 | 1.5 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.5 | 0.5 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
0.5 | 1.0 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.5 | 2.5 | GO:0002934 | desmosome organization(GO:0002934) |
0.5 | 1.0 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.5 | 9.6 | GO:0016180 | snRNA processing(GO:0016180) |
0.5 | 0.5 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.5 | 2.0 | GO:0019985 | translesion synthesis(GO:0019985) |
0.5 | 3.0 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.5 | 12.0 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
0.5 | 4.0 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.5 | 4.0 | GO:0031297 | replication fork processing(GO:0031297) |
0.5 | 2.5 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.5 | 3.0 | GO:0034204 | lipid translocation(GO:0034204) |
0.5 | 1.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.5 | 1.0 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.5 | 0.5 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.5 | 1.5 | GO:0050779 | RNA destabilization(GO:0050779) |
0.5 | 1.0 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.5 | 4.9 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.5 | 1.5 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.5 | 3.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.5 | 1.5 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.5 | 1.5 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.5 | 2.5 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.5 | 2.5 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.5 | 2.4 | GO:0051013 | microtubule severing(GO:0051013) |
0.5 | 1.0 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.5 | 0.5 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.5 | 1.0 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.5 | 1.9 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.5 | 5.8 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.5 | 0.5 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.5 | 13.0 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.5 | 0.5 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.5 | 0.5 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
0.5 | 6.7 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.5 | 1.0 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.5 | 1.0 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.5 | 3.8 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.5 | 1.4 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.5 | 4.3 | GO:0030033 | microvillus assembly(GO:0030033) |
0.5 | 2.9 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.5 | 3.3 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.5 | 3.3 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.5 | 7.1 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.5 | 2.4 | GO:0009648 | photoperiodism(GO:0009648) |
0.5 | 0.5 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.5 | 1.9 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.5 | 1.4 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.5 | 2.4 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.5 | 0.5 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.5 | 2.3 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.5 | 0.9 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.5 | 0.5 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.5 | 1.9 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.5 | 3.7 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.5 | 3.2 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.5 | 4.1 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.5 | 0.9 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.5 | 0.9 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.5 | 2.3 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.5 | 0.5 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.5 | 1.8 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.5 | 3.6 | GO:0001675 | acrosome assembly(GO:0001675) |
0.5 | 2.3 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.5 | 1.4 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.4 | 0.4 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.4 | 0.4 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.4 | 7.2 | GO:0016925 | protein sumoylation(GO:0016925) |
0.4 | 1.8 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.4 | 0.9 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.4 | 1.8 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.4 | 0.9 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.4 | 1.8 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.4 | 2.2 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.4 | 1.8 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.4 | 0.9 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.4 | 0.4 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.4 | 1.3 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.4 | 1.3 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.4 | 3.5 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.4 | 1.3 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.4 | 0.9 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.4 | 3.1 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.4 | 5.3 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.4 | 3.5 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.4 | 0.9 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.4 | 18.0 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.4 | 1.8 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.4 | 0.4 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.4 | 0.4 | GO:0090399 | replicative senescence(GO:0090399) |
0.4 | 3.5 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.4 | 0.4 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.4 | 3.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.4 | 1.3 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.4 | 2.6 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.4 | 1.3 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.4 | 2.2 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.4 | 4.3 | GO:0001967 | suckling behavior(GO:0001967) |
0.4 | 1.3 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.4 | 2.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.4 | 2.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.4 | 2.6 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.4 | 2.5 | GO:0007379 | segment specification(GO:0007379) |
0.4 | 4.2 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.4 | 0.8 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
0.4 | 0.4 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.4 | 1.3 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.4 | 8.4 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.4 | 1.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.4 | 0.4 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.4 | 3.3 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.4 | 0.4 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.4 | 1.7 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.4 | 0.4 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.4 | 3.7 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.4 | 0.4 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.4 | 1.2 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.4 | 1.2 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.4 | 0.8 | GO:0050904 | diapedesis(GO:0050904) |
0.4 | 0.8 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.4 | 2.9 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.4 | 2.5 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.4 | 1.6 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.4 | 1.2 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.4 | 2.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.4 | 10.3 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.4 | 0.4 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.4 | 1.2 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.4 | 1.2 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.4 | 1.2 | GO:1902745 | positive regulation of lamellipodium organization(GO:1902745) |
0.4 | 4.5 | GO:0001893 | maternal placenta development(GO:0001893) |
0.4 | 0.8 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.4 | 2.0 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.4 | 2.0 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.4 | 1.2 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.4 | 15.7 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.4 | 0.4 | GO:0014889 | muscle atrophy(GO:0014889) |
0.4 | 2.0 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.4 | 0.8 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.4 | 2.0 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.4 | 3.2 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.4 | 1.2 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.4 | 1.2 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.4 | 1.2 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
0.4 | 0.8 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.4 | 1.6 | GO:0060283 | negative regulation of oocyte development(GO:0060283) |
0.4 | 1.6 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.4 | 2.0 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.4 | 0.8 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.4 | 2.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.4 | 1.9 | GO:0033572 | transferrin transport(GO:0033572) |
0.4 | 1.2 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.4 | 1.2 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.4 | 0.8 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.4 | 2.3 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.4 | 0.4 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.4 | 3.8 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.4 | 1.9 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.4 | 1.5 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.4 | 1.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.4 | 3.8 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.4 | 1.1 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.4 | 0.8 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.4 | 0.8 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.4 | 1.5 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.4 | 2.6 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.4 | 3.0 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.4 | 1.9 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.4 | 1.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.4 | 1.5 | GO:0006907 | pinocytosis(GO:0006907) |
0.4 | 3.8 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.4 | 2.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.4 | 3.4 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.4 | 0.4 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.4 | 0.4 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.4 | 2.2 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.4 | 1.5 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.4 | 1.1 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.4 | 0.7 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.4 | 1.1 | GO:0042546 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.4 | 0.7 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.4 | 1.1 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.4 | 0.7 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.4 | 0.7 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.4 | 9.2 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.4 | 0.7 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.4 | 0.4 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.4 | 1.8 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.4 | 0.4 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.4 | 1.1 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.4 | 3.3 | GO:0007097 | nuclear migration(GO:0007097) |
0.4 | 0.7 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.4 | 0.7 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.4 | 1.8 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.4 | 6.5 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.4 | 3.2 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.4 | 0.7 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.4 | 1.8 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
0.4 | 7.5 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.4 | 0.7 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.4 | 4.6 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.4 | 1.1 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.4 | 1.8 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.4 | 1.1 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.4 | 18.7 | GO:0051028 | mRNA transport(GO:0051028) |
0.4 | 1.8 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.4 | 0.4 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.4 | 0.7 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.3 | 12.9 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.3 | 4.9 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.3 | 0.7 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.3 | 0.3 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.3 | 0.7 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.3 | 2.1 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.3 | 4.5 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.3 | 5.9 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.3 | 1.0 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.3 | 2.8 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.3 | 0.3 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.3 | 2.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.3 | 1.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.3 | 3.4 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.3 | 1.0 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.3 | 0.7 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.3 | 0.3 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.3 | 0.7 | GO:0048102 | autophagic cell death(GO:0048102) |
0.3 | 0.3 | GO:0045978 | negative regulation of nucleoside metabolic process(GO:0045978) negative regulation of ATP metabolic process(GO:1903579) |
0.3 | 2.7 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.3 | 3.4 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.3 | 1.7 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.3 | 0.3 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.3 | 0.7 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.3 | 1.3 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.3 | 6.7 | GO:0006491 | N-glycan processing(GO:0006491) |
0.3 | 2.7 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.3 | 1.3 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.3 | 1.0 | GO:0032049 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin biosynthetic process(GO:0032049) |
0.3 | 0.3 | GO:1904738 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) |
0.3 | 0.7 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.3 | 1.0 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.3 | 1.0 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.3 | 2.0 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.3 | 2.0 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.3 | 2.3 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.3 | 1.3 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.3 | 0.7 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.3 | 0.3 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.3 | 1.0 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.3 | 3.6 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.3 | 1.6 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.3 | 1.6 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.3 | 1.3 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.3 | 7.8 | GO:0051591 | response to cAMP(GO:0051591) |
0.3 | 5.5 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.3 | 0.3 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.3 | 2.3 | GO:0019068 | virion assembly(GO:0019068) |
0.3 | 2.3 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.3 | 0.6 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.3 | 1.3 | GO:0051014 | actin filament severing(GO:0051014) |
0.3 | 4.5 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.3 | 1.3 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.3 | 5.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.3 | 0.3 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
0.3 | 6.0 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.3 | 1.0 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.3 | 0.3 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.3 | 0.3 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.3 | 1.3 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.3 | 1.3 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.3 | 0.3 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.3 | 0.6 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.3 | 0.9 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.3 | 4.7 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.3 | 1.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.3 | 0.9 | GO:0015817 | histidine transport(GO:0015817) |
0.3 | 0.6 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.3 | 0.9 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.3 | 0.6 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.3 | 0.3 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.3 | 0.6 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.3 | 0.6 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.3 | 0.9 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.3 | 0.6 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.3 | 2.5 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.3 | 1.2 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.3 | 0.6 | GO:0006573 | valine metabolic process(GO:0006573) |
0.3 | 0.6 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.3 | 0.6 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.3 | 0.6 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.3 | 0.6 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.3 | 0.9 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.3 | 2.1 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.3 | 0.6 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) positive regulation of translational initiation in response to stress(GO:0032058) |
0.3 | 1.5 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.3 | 0.3 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.3 | 0.3 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) |
0.3 | 0.9 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.3 | 2.1 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.3 | 4.5 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.3 | 0.6 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.3 | 1.2 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.3 | 0.9 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.3 | 0.6 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.3 | 0.9 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.3 | 0.6 | GO:0042993 | positive regulation of transcription factor import into nucleus(GO:0042993) |
0.3 | 1.5 | GO:0034063 | stress granule assembly(GO:0034063) |
0.3 | 0.3 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.3 | 1.2 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.3 | 0.3 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.3 | 1.8 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 | 3.2 | GO:0060337 | type I interferon signaling pathway(GO:0060337) |
0.3 | 0.6 | GO:1903392 | negative regulation of adherens junction organization(GO:1903392) |
0.3 | 0.6 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.3 | 2.0 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.3 | 0.3 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.3 | 0.9 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.3 | 0.6 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.3 | 3.5 | GO:0071385 | cellular response to glucocorticoid stimulus(GO:0071385) |
0.3 | 4.6 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.3 | 0.6 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.3 | 2.0 | GO:0009299 | mRNA transcription(GO:0009299) |
0.3 | 0.6 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.3 | 0.9 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
0.3 | 2.0 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.3 | 4.9 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.3 | 0.6 | GO:0097460 | ferrous iron import(GO:0070627) ferrous iron import into cell(GO:0097460) |
0.3 | 1.4 | GO:0006903 | vesicle targeting(GO:0006903) |
0.3 | 0.3 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.3 | 1.1 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.3 | 0.8 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.3 | 4.8 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.3 | 2.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.3 | 0.8 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.3 | 0.8 | GO:1904356 | regulation of telomere maintenance via telomere lengthening(GO:1904356) |
0.3 | 0.8 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.3 | 0.8 | GO:2000561 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.3 | 1.4 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.3 | 1.1 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.3 | 3.3 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.3 | 0.8 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.3 | 3.6 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.3 | 0.6 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.3 | 0.3 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.3 | 1.7 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.3 | 0.8 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.3 | 2.2 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.3 | 0.3 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.3 | 1.4 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.3 | 10.6 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.3 | 0.8 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.3 | 4.1 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.3 | 0.5 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.3 | 0.3 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.3 | 0.5 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.3 | 2.4 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.3 | 0.3 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.3 | 1.3 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.3 | 0.8 | GO:0070266 | necroptotic process(GO:0070266) |
0.3 | 0.5 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.3 | 0.3 | GO:0035384 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
0.3 | 2.1 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.3 | 0.3 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.3 | 0.5 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.3 | 2.9 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.3 | 2.7 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.3 | 0.5 | GO:0051256 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.3 | 0.8 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.3 | 2.4 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.3 | 6.3 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.3 | 0.3 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.3 | 1.3 | GO:0010225 | response to UV-C(GO:0010225) |
0.3 | 0.8 | GO:0018101 | protein citrullination(GO:0018101) |
0.3 | 4.5 | GO:0071824 | protein-DNA complex subunit organization(GO:0071824) |
0.3 | 0.3 | GO:0055057 | neuronal stem cell division(GO:0036445) neuroblast division(GO:0055057) |
0.3 | 4.2 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.3 | 0.5 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.3 | 2.3 | GO:0009303 | rRNA transcription(GO:0009303) |
0.3 | 2.1 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.3 | 0.5 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.3 | 1.3 | GO:0003356 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
0.3 | 0.3 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.3 | 0.3 | GO:0019042 | viral latency(GO:0019042) |
0.3 | 2.3 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.3 | 1.0 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.3 | 0.8 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.3 | 0.5 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.3 | 1.0 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.3 | 1.8 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.3 | 0.5 | GO:0003072 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.3 | 2.0 | GO:0034331 | cell junction maintenance(GO:0034331) |
0.3 | 0.5 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.3 | 0.5 | GO:0044346 | fibroblast apoptotic process(GO:0044346) |
0.3 | 2.0 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.3 | 0.8 | GO:0043248 | proteasome assembly(GO:0043248) |
0.3 | 1.0 | GO:0006415 | translational termination(GO:0006415) |
0.3 | 0.5 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.3 | 1.5 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.3 | 1.3 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.3 | 0.3 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.3 | 0.3 | GO:0032682 | negative regulation of chemokine production(GO:0032682) |
0.2 | 0.5 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.2 | 0.7 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
0.2 | 2.2 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.2 | 1.7 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 | 1.2 | GO:0018198 | peptidyl-cysteine modification(GO:0018198) |
0.2 | 1.2 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.2 | 0.5 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.2 | 7.4 | GO:0007030 | Golgi organization(GO:0007030) |
0.2 | 0.7 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 9.6 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.2 | 0.7 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
0.2 | 0.7 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.2 | 2.4 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.2 | 1.0 | GO:0048260 | positive regulation of receptor-mediated endocytosis(GO:0048260) |
0.2 | 24.1 | GO:0016568 | chromatin modification(GO:0016568) |
0.2 | 1.7 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.2 | 1.9 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.2 | 1.2 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.2 | 0.2 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.2 | 0.5 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.2 | 0.5 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.2 | 0.5 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.2 | 0.7 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.2 | 1.7 | GO:1902116 | negative regulation of cilium assembly(GO:1902018) negative regulation of organelle assembly(GO:1902116) |
0.2 | 1.4 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.2 | 0.5 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.2 | 0.7 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.2 | 0.2 | GO:0046066 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.2 | 0.2 | GO:0048143 | astrocyte activation(GO:0048143) |
0.2 | 1.4 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.2 | 0.2 | GO:0051665 | membrane raft localization(GO:0051665) |
0.2 | 0.2 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.2 | 1.7 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.2 | 0.5 | GO:1903299 | regulation of hexokinase activity(GO:1903299) |
0.2 | 0.9 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.2 | 0.5 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 1.2 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.2 | 0.9 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.2 | 0.2 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.2 | 0.9 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.2 | 0.7 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.2 | 0.2 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.2 | 2.5 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.2 | 1.8 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.2 | 0.7 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.2 | 0.5 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.2 | 0.5 | GO:0098751 | bone cell development(GO:0098751) |
0.2 | 0.9 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.2 | 0.9 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.2 | 1.4 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 0.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.2 | 0.4 | GO:0051084 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.2 | 0.4 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.2 | 0.9 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 0.9 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.2 | 0.7 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 0.2 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.2 | 0.7 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.2 | 0.2 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.2 | 0.7 | GO:0009838 | abscission(GO:0009838) |
0.2 | 0.4 | GO:0032570 | response to progesterone(GO:0032570) |
0.2 | 0.7 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 0.9 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.2 | 0.7 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 | 0.9 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.2 | 0.9 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.2 | 0.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 1.1 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.2 | 0.7 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.2 | 0.7 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.2 | 0.9 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 0.6 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.2 | 1.5 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.2 | 0.6 | GO:0045056 | transcytosis(GO:0045056) |
0.2 | 1.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 0.6 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.2 | 0.4 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.2 | 2.1 | GO:0031167 | rRNA methylation(GO:0031167) |
0.2 | 3.7 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.2 | 0.6 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.2 | 0.2 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.2 | 0.2 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.2 | 0.4 | GO:0015886 | heme transport(GO:0015886) |
0.2 | 4.1 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.2 | 0.4 | GO:0030575 | nuclear body organization(GO:0030575) |
0.2 | 0.6 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.2 | 3.2 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.2 | 0.8 | GO:0043471 | regulation of carbohydrate catabolic process(GO:0043470) regulation of cellular carbohydrate catabolic process(GO:0043471) |
0.2 | 0.6 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.2 | 0.4 | GO:1903203 | neuron death in response to oxidative stress(GO:0036475) regulation of oxidative stress-induced neuron death(GO:1903203) |
0.2 | 2.1 | GO:1904358 | positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.2 | 0.8 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.2 | 1.5 | GO:0060612 | adipose tissue development(GO:0060612) |
0.2 | 0.6 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process through glucose-1-phosphate(GO:0061622) glycolytic process from galactose(GO:0061623) |
0.2 | 0.8 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.2 | 2.7 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.2 | 0.6 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 0.6 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.2 | 0.2 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.2 | 0.6 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.2 | 0.6 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.2 | 1.0 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 0.6 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.2 | 9.5 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.2 | 1.7 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.2 | 0.4 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 1.4 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 1.6 | GO:0051168 | nuclear export(GO:0051168) |
0.2 | 1.2 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.2 | 0.6 | GO:0019441 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.2 | 0.8 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.2 | 0.2 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.2 | 0.4 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.2 | 5.9 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.2 | 0.6 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.2 | 0.2 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.2 | 0.4 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.2 | 0.6 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.2 | 0.4 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.2 | 0.4 | GO:0030576 | Cajal body organization(GO:0030576) |
0.2 | 1.4 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.2 | 0.8 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.2 | 1.6 | GO:0002021 | response to dietary excess(GO:0002021) |
0.2 | 0.2 | GO:0010822 | positive regulation of mitochondrion organization(GO:0010822) |
0.2 | 0.6 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.2 | 1.8 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.2 | 0.2 | GO:2000665 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) positive regulation of interleukin-5 secretion(GO:2000664) regulation of interleukin-13 secretion(GO:2000665) positive regulation of interleukin-13 secretion(GO:2000667) |
0.2 | 0.6 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.2 | 1.2 | GO:0009148 | pyrimidine nucleoside triphosphate biosynthetic process(GO:0009148) |
0.2 | 0.6 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.2 | 0.6 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.2 | 0.2 | GO:0015755 | fructose transport(GO:0015755) |
0.2 | 0.6 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.2 | 2.3 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.2 | 1.2 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.2 | 1.3 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.2 | 0.4 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 3.3 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.2 | 1.0 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.2 | 1.9 | GO:1901663 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.2 | 0.2 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.2 | 4.4 | GO:0030837 | negative regulation of actin filament polymerization(GO:0030837) |
0.2 | 0.4 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.2 | 1.1 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.2 | 0.2 | GO:0010536 | regulation of activation of Janus kinase activity(GO:0010533) positive regulation of activation of Janus kinase activity(GO:0010536) |
0.2 | 0.2 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.2 | 0.6 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.2 | 0.6 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.2 | 0.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.2 | 0.6 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.2 | 3.0 | GO:0007569 | cell aging(GO:0007569) |
0.2 | 0.2 | GO:0051985 | negative regulation of chromosome segregation(GO:0051985) |
0.2 | 0.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.2 | 2.6 | GO:1901998 | toxin transport(GO:1901998) |
0.2 | 0.4 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.2 | 0.6 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 1.3 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.2 | 2.4 | GO:0021591 | ventricular system development(GO:0021591) |
0.2 | 1.3 | GO:0048599 | oocyte development(GO:0048599) |
0.2 | 0.2 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.2 | 1.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 0.2 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.2 | 0.2 | GO:0030913 | protein localization to paranode region of axon(GO:0002175) paranodal junction assembly(GO:0030913) |
0.2 | 2.4 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.2 | 1.1 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.2 | 0.2 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.2 | 0.7 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.2 | 0.2 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) |
0.2 | 0.5 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.2 | 0.5 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.2 | 0.5 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
0.2 | 0.4 | GO:0051031 | tRNA transport(GO:0051031) |
0.2 | 0.2 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.2 | 0.7 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 0.5 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.2 | 0.3 | GO:0030421 | defecation(GO:0030421) |
0.2 | 0.2 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.2 | 0.8 | GO:1904970 | brush border assembly(GO:1904970) |
0.2 | 9.1 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.2 | 0.3 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.2 | 25.0 | GO:0016567 | protein ubiquitination(GO:0016567) |
0.2 | 1.2 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.2 | 1.0 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.2 | 0.3 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.2 | 0.7 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.2 | 0.3 | GO:0060068 | vagina development(GO:0060068) |
0.2 | 1.5 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.2 | 0.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.2 | 1.3 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.2 | 0.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 0.5 | GO:0015791 | polyol transport(GO:0015791) |
0.2 | 0.8 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.2 | 1.1 | GO:0016926 | protein desumoylation(GO:0016926) |
0.2 | 0.2 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.2 | 1.3 | GO:0033866 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.2 | 0.2 | GO:0060057 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.2 | 0.2 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.2 | 0.6 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.2 | 0.6 | GO:0000012 | single strand break repair(GO:0000012) |
0.2 | 0.3 | GO:0050955 | thermoception(GO:0050955) |
0.2 | 0.2 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.2 | 0.3 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.2 | 1.0 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.2 | 0.6 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.2 | 1.1 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.2 | 0.2 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.2 | 4.8 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 0.2 | GO:0036314 | response to sterol(GO:0036314) |
0.2 | 3.0 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.2 | 1.3 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.2 | 0.5 | GO:0042424 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.2 | 0.2 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.2 | 0.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.2 | 0.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.2 | 0.3 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 0.2 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.2 | 0.6 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.2 | 0.6 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.2 | 0.3 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) nucleotide transmembrane transport(GO:1901679) |
0.2 | 0.8 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
0.2 | 2.0 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.2 | 0.2 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 0.2 | GO:0051299 | centrosome separation(GO:0051299) |
0.2 | 2.6 | GO:0010324 | membrane invagination(GO:0010324) |
0.2 | 0.2 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.2 | 0.5 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.2 | 0.5 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.2 | 0.6 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.4 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.1 | 0.3 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.9 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 2.5 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.1 | 0.9 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.1 | 22.4 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 0.4 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.9 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.3 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.1 | 0.7 | GO:0038061 | NIK/NF-kappaB signaling(GO:0038061) |
0.1 | 0.3 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.4 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 0.3 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.1 | 0.9 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.1 | GO:0070305 | response to cGMP(GO:0070305) |
0.1 | 4.4 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.1 | 5.6 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.1 | 0.6 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.1 | 0.9 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 3.7 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.4 | GO:0042454 | ribonucleoside catabolic process(GO:0042454) |
0.1 | 0.3 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.1 | 0.3 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.1 | 0.4 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 0.4 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.1 | 3.4 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.8 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 0.4 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.1 | 0.7 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.1 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.1 | 4.9 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.1 | 0.3 | GO:0033753 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.1 | 0.4 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 1.4 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.1 | 4.5 | GO:1902652 | secondary alcohol metabolic process(GO:1902652) |
0.1 | 0.8 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.1 | 0.4 | GO:0061515 | myeloid cell development(GO:0061515) |
0.1 | 0.8 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 0.5 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.1 | 0.5 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.1 | 0.3 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 7.8 | GO:0017148 | negative regulation of translation(GO:0017148) |
0.1 | 0.7 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.1 | 0.3 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) |
0.1 | 0.4 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.8 | GO:0071435 | potassium ion export(GO:0071435) |
0.1 | 0.4 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.1 | 0.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.1 | 0.1 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.5 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.9 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.7 | GO:0014887 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.1 | 0.3 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.3 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.1 | 0.1 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
0.1 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 1.5 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.3 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.1 | 0.1 | GO:1900077 | negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.1 | 0.8 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.1 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.1 | 0.1 | GO:0071332 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
0.1 | 0.3 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.1 | 0.1 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.1 | 0.5 | GO:2000209 | regulation of anoikis(GO:2000209) |
0.1 | 0.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.1 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 0.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.2 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.7 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 1.2 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.4 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.5 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.8 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 1.7 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.1 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.1 | 0.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.1 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.1 | 0.7 | GO:0023058 | adaptation of signaling pathway(GO:0023058) |
0.1 | 0.2 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 0.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 12.6 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.1 | 0.3 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 0.2 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.1 | 0.1 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.1 | 0.2 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 0.2 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.1 | 1.6 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.1 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.1 | 0.2 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.1 | 0.3 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.1 | 0.6 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.1 | 26.2 | GO:0043043 | peptide biosynthetic process(GO:0043043) |
0.1 | 1.3 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 0.4 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.3 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.1 | 0.1 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.1 | 0.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 0.3 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 0.1 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.1 | 1.2 | GO:0070585 | protein localization to mitochondrion(GO:0070585) |
0.1 | 0.7 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.1 | 1.5 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 0.6 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.1 | 0.1 | GO:0010332 | response to gamma radiation(GO:0010332) |
0.1 | 0.5 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.1 | 0.4 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.9 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.1 | 0.2 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.1 | 0.1 | GO:2000211 | negative regulation of cellular amine metabolic process(GO:0033239) regulation of glutamate metabolic process(GO:2000211) |
0.1 | 0.3 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.1 | 0.3 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.2 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.1 | GO:0002576 | platelet degranulation(GO:0002576) |
0.1 | 0.4 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
0.1 | 0.1 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) negative regulation of intestinal absorption(GO:1904479) |
0.1 | 1.0 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 0.6 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.2 | GO:0034340 | response to type I interferon(GO:0034340) |
0.1 | 1.1 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.1 | 0.2 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 1.8 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.2 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.2 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 2.5 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
0.1 | 0.1 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.1 | 0.2 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.1 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 0.2 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 0.1 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.1 | 0.4 | GO:0042737 | drug catabolic process(GO:0042737) |
0.1 | 0.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.1 | 0.1 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.1 | 1.5 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 0.9 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.5 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.8 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.1 | 0.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.3 | GO:0006536 | glutamate metabolic process(GO:0006536) |
0.1 | 1.1 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.1 | 0.1 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.1 | 0.4 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 0.1 | GO:0010560 | positive regulation of glycoprotein biosynthetic process(GO:0010560) |
0.1 | 4.4 | GO:0022613 | ribonucleoprotein complex biogenesis(GO:0022613) |
0.1 | 1.4 | GO:0031023 | microtubule organizing center organization(GO:0031023) |
0.1 | 0.2 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 0.2 | GO:1900040 | regulation of interleukin-2 secretion(GO:1900040) |
0.1 | 3.0 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.2 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 1.0 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.1 | 0.2 | GO:0032743 | positive regulation of interleukin-2 production(GO:0032743) |
0.1 | 0.1 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.1 | 0.3 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.1 | 0.4 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 1.3 | GO:0065002 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.1 | 0.2 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 0.7 | GO:0007041 | lysosomal transport(GO:0007041) |
0.1 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 0.1 | GO:0032108 | negative regulation of response to extracellular stimulus(GO:0032105) negative regulation of response to nutrient levels(GO:0032108) |
0.1 | 1.1 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 0.1 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 0.7 | GO:0071901 | negative regulation of protein serine/threonine kinase activity(GO:0071901) |
0.1 | 0.1 | GO:0043455 | regulation of secondary metabolic process(GO:0043455) |
0.1 | 0.3 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.1 | 0.3 | GO:0010714 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.1 | 0.3 | GO:0034627 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 1.0 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.2 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.1 | 0.1 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.1 | 0.1 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.1 | 0.2 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.1 | 0.2 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.2 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 0.3 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.1 | GO:0071838 | cell proliferation in bone marrow(GO:0071838) positive regulation of cell proliferation in bone marrow(GO:0071864) |
0.1 | 1.3 | GO:0050821 | protein stabilization(GO:0050821) |
0.1 | 0.3 | GO:0006475 | internal protein amino acid acetylation(GO:0006475) |
0.1 | 1.4 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.1 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.1 | GO:0034123 | positive regulation of toll-like receptor signaling pathway(GO:0034123) |
0.1 | 0.4 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.1 | 0.7 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.1 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.1 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 0.2 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.1 | 0.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 2.0 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 3.3 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.5 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.1 | 0.8 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.2 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.1 | 0.1 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.1 | 0.4 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.1 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.2 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.1 | 0.4 | GO:0009206 | purine ribonucleoside triphosphate biosynthetic process(GO:0009206) |
0.1 | 0.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.4 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.1 | 0.1 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 0.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 0.1 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.7 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.4 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.1 | 0.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.3 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 0.1 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
0.1 | 0.1 | GO:0034032 | nucleoside bisphosphate metabolic process(GO:0033865) ribonucleoside bisphosphate metabolic process(GO:0033875) purine nucleoside bisphosphate metabolic process(GO:0034032) |
0.1 | 0.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 | 2.9 | GO:0034470 | ncRNA processing(GO:0034470) |
0.1 | 0.1 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.3 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.1 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.1 | 0.1 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.1 | 1.9 | GO:0046777 | protein autophosphorylation(GO:0046777) |
0.1 | 0.4 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.1 | 0.4 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.1 | 0.1 | GO:1903311 | regulation of mRNA metabolic process(GO:1903311) |
0.1 | 0.1 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.1 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.5 | GO:0002251 | organ or tissue specific immune response(GO:0002251) |
0.1 | 0.1 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.1 | 0.1 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.1 | 0.8 | GO:0002708 | positive regulation of lymphocyte mediated immunity(GO:0002708) |
0.1 | 0.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.1 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.1 | 1.1 | GO:0051302 | regulation of cell division(GO:0051302) |
0.1 | 3.3 | GO:0032259 | methylation(GO:0032259) |
0.1 | 0.3 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.1 | 0.5 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 0.1 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 0.2 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 0.1 | GO:0051645 | Golgi localization(GO:0051645) |
0.1 | 0.1 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.1 | 0.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.1 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.1 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.1 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.1 | 0.2 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 0.4 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 0.1 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.1 | 0.3 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 0.1 | GO:1903430 | negative regulation of cell maturation(GO:1903430) |
0.1 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.1 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 0.1 | GO:1903052 | positive regulation of proteolysis involved in cellular protein catabolic process(GO:1903052) |
0.1 | 0.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.1 | GO:0034114 | regulation of heterotypic cell-cell adhesion(GO:0034114) positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.1 | 0.2 | GO:0042670 | retinal cone cell differentiation(GO:0042670) |
0.1 | 0.2 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.0 | 0.1 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.0 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.0 | 0.8 | GO:0009060 | aerobic respiration(GO:0009060) |
0.0 | 0.3 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.0 | 0.2 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.0 | 0.0 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.0 | 0.2 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
0.0 | 0.1 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.0 | 0.0 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.0 | 0.0 | GO:0007004 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.0 | 0.0 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.0 | 0.4 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
0.0 | 0.2 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.0 | 0.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.0 | 0.0 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.0 | GO:0009264 | deoxyribonucleotide catabolic process(GO:0009264) |
0.0 | 0.0 | GO:0072677 | eosinophil migration(GO:0072677) |
0.0 | 0.0 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.0 | 0.3 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.0 | 0.0 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.0 | 0.7 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.0 | 1.8 | GO:0019941 | modification-dependent protein catabolic process(GO:0019941) |
0.0 | 0.4 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.0 | 0.0 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.0 | 0.1 | GO:0032200 | telomere maintenance(GO:0000723) telomere organization(GO:0032200) |
0.0 | 0.5 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.0 | 0.0 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.3 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.0 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.0 | 0.0 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.0 | 0.3 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
0.0 | 0.3 | GO:0042730 | fibrinolysis(GO:0042730) |
0.0 | 0.6 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.1 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.5 | GO:0045682 | regulation of epidermis development(GO:0045682) |
0.0 | 0.0 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.0 | 0.0 | GO:0044033 | multi-organism metabolic process(GO:0044033) |
0.0 | 0.3 | GO:0035966 | response to topologically incorrect protein(GO:0035966) |
0.0 | 0.0 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.0 | 0.1 | GO:0015744 | succinate transport(GO:0015744) |
0.0 | 0.1 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.0 | 0.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.0 | 0.1 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.0 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.1 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.0 | 0.1 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
0.0 | 0.0 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.0 | 0.0 | GO:0001923 | B-1 B cell differentiation(GO:0001923) B-1a B cell differentiation(GO:0002337) |
0.0 | 0.1 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.0 | 0.0 | GO:0046503 | glycerolipid catabolic process(GO:0046503) |
0.0 | 0.1 | GO:0002702 | positive regulation of production of molecular mediator of immune response(GO:0002702) |
0.0 | 0.1 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.0 | 0.5 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.5 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.0 | 0.0 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.0 | 0.0 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) negative regulation of gastric acid secretion(GO:0060455) |
0.0 | 0.2 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.0 | 0.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.0 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.0 | 0.0 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.0 | 0.9 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) |
0.0 | 0.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.3 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.0 | 0.3 | GO:0017144 | drug metabolic process(GO:0017144) |
0.0 | 0.4 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.0 | 0.3 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.0 | 0.0 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.0 | 0.2 | GO:0043297 | apical junction assembly(GO:0043297) |
0.0 | 0.0 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.0 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.1 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.0 | 0.0 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.3 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.0 | 0.0 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.1 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.0 | 0.0 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.0 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.0 | 0.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.0 | GO:0043276 | anoikis(GO:0043276) |
0.0 | 0.0 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.0 | 0.4 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.1 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.1 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.0 | GO:0072608 | interleukin-10 secretion(GO:0072608) regulation of interleukin-10 secretion(GO:2001179) |
0.0 | 0.1 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.1 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.0 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.0 | 0.0 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.0 | 0.0 | GO:0010039 | response to iron ion(GO:0010039) |
0.0 | 0.1 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 0.0 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.0 | 1.3 | GO:0051607 | defense response to virus(GO:0051607) |
0.0 | 0.2 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.0 | 0.0 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.0 | 0.0 | GO:0072678 | T cell migration(GO:0072678) |
0.0 | 0.1 | GO:1901071 | glucosamine-containing compound metabolic process(GO:1901071) |
0.0 | 0.2 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.0 | 0.1 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.0 | 0.1 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.0 | 0.0 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.0 | 0.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.0 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.0 | 0.0 | GO:0060416 | response to growth hormone(GO:0060416) |
0.0 | 0.0 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.0 | 0.1 | GO:0070269 | pyroptosis(GO:0070269) |
0.0 | 0.0 | GO:1900221 | regulation of beta-amyloid clearance(GO:1900221) |
0.0 | 0.0 | GO:0034660 | ncRNA metabolic process(GO:0034660) |
0.0 | 0.0 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.0 | 0.0 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.0 | 0.0 | GO:0042488 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) |
0.0 | 0.0 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.0 | 0.0 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.0 | 0.5 | GO:0006260 | DNA replication(GO:0006260) |
0.0 | 0.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.9 | GO:0071219 | cellular response to molecule of bacterial origin(GO:0071219) |
0.0 | 0.1 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
0.0 | 0.0 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.0 | 0.0 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.0 | 0.0 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.0 | 0.0 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.0 | 0.0 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.0 | 0.0 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.0 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.0 | 0.1 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.1 | GO:0009615 | response to virus(GO:0009615) |
0.0 | 0.0 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.0 | 0.2 | GO:0009813 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.0 | 0.0 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.0 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.0 | 0.0 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.0 | 16.0 | GO:0072487 | MSL complex(GO:0072487) |
2.9 | 23.1 | GO:0001650 | fibrillar center(GO:0001650) |
2.8 | 8.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
2.6 | 15.6 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
2.5 | 10.2 | GO:0005955 | calcineurin complex(GO:0005955) |
2.4 | 9.6 | GO:0005642 | annulate lamellae(GO:0005642) |
2.3 | 7.0 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
2.2 | 6.6 | GO:0048179 | activin receptor complex(GO:0048179) |
2.2 | 6.5 | GO:0031417 | NatC complex(GO:0031417) |
2.0 | 44.0 | GO:0090544 | BAF-type complex(GO:0090544) |
1.9 | 7.6 | GO:0016589 | NURF complex(GO:0016589) |
1.9 | 9.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.9 | 18.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
1.8 | 7.2 | GO:0005667 | transcription factor complex(GO:0005667) |
1.8 | 73.5 | GO:0031519 | PcG protein complex(GO:0031519) |
1.8 | 7.0 | GO:0071141 | SMAD protein complex(GO:0071141) |
1.7 | 5.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.6 | 3.2 | GO:0032437 | cuticular plate(GO:0032437) |
1.6 | 6.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
1.5 | 1.5 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
1.5 | 4.6 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
1.5 | 10.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
1.5 | 7.3 | GO:0000235 | astral microtubule(GO:0000235) |
1.5 | 5.8 | GO:0031010 | ISWI-type complex(GO:0031010) |
1.4 | 5.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.4 | 4.3 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
1.4 | 5.6 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
1.3 | 39.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
1.3 | 5.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
1.3 | 5.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
1.3 | 3.8 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
1.2 | 4.8 | GO:0000938 | GARP complex(GO:0000938) |
1.2 | 16.5 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
1.2 | 22.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
1.1 | 4.6 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
1.1 | 4.6 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
1.1 | 11.3 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
1.1 | 17.8 | GO:0010369 | chromocenter(GO:0010369) |
1.1 | 2.2 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.1 | 5.4 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.1 | 9.6 | GO:0000124 | SAGA complex(GO:0000124) |
1.1 | 4.2 | GO:0008091 | spectrin(GO:0008091) |
1.0 | 4.2 | GO:0030056 | hemidesmosome(GO:0030056) |
1.0 | 3.1 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.0 | 6.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
1.0 | 8.3 | GO:1990909 | Wnt signalosome(GO:1990909) |
1.0 | 4.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
1.0 | 4.1 | GO:0001940 | male pronucleus(GO:0001940) |
1.0 | 2.0 | GO:0070688 | MLL5-L complex(GO:0070688) |
1.0 | 53.6 | GO:0000118 | histone deacetylase complex(GO:0000118) |
1.0 | 7.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.0 | 6.0 | GO:0031415 | NatA complex(GO:0031415) |
1.0 | 4.0 | GO:0097524 | sperm plasma membrane(GO:0097524) |
1.0 | 4.0 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
1.0 | 1.0 | GO:0005726 | perichromatin fibrils(GO:0005726) |
1.0 | 3.9 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
1.0 | 16.6 | GO:0005719 | nuclear euchromatin(GO:0005719) |
1.0 | 52.9 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
1.0 | 67.7 | GO:0016363 | nuclear matrix(GO:0016363) |
0.9 | 4.7 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.9 | 1.9 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.9 | 18.5 | GO:0000786 | nucleosome(GO:0000786) |
0.9 | 2.7 | GO:0036396 | MIS complex(GO:0036396) |
0.9 | 6.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.9 | 3.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.9 | 2.6 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.9 | 12.2 | GO:0031528 | microvillus membrane(GO:0031528) |
0.9 | 0.9 | GO:0097513 | myosin II filament(GO:0097513) |
0.9 | 3.5 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.9 | 2.6 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.8 | 2.5 | GO:0030870 | Mre11 complex(GO:0030870) |
0.8 | 11.9 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.8 | 6.7 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.8 | 32.7 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.8 | 6.4 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.8 | 0.8 | GO:0016939 | kinesin II complex(GO:0016939) |
0.8 | 23.9 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.8 | 3.2 | GO:0097433 | dense body(GO:0097433) |
0.8 | 15.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.8 | 5.5 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.8 | 3.1 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.8 | 11.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.8 | 10.0 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.8 | 3.0 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.8 | 0.8 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.7 | 2.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.7 | 2.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.7 | 10.3 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.7 | 2.9 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.7 | 0.7 | GO:0005687 | U4 snRNP(GO:0005687) |
0.7 | 5.8 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.7 | 4.3 | GO:0042587 | glycogen granule(GO:0042587) |
0.7 | 1.4 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.7 | 2.8 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.7 | 1.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.7 | 5.7 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.7 | 38.3 | GO:0016605 | PML body(GO:0016605) |
0.7 | 5.0 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.7 | 8.5 | GO:0038201 | TOR complex(GO:0038201) |
0.7 | 0.7 | GO:0072686 | mitotic spindle(GO:0072686) |
0.7 | 2.8 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.7 | 23.1 | GO:0016592 | mediator complex(GO:0016592) |
0.7 | 2.8 | GO:0030891 | VCB complex(GO:0030891) |
0.7 | 2.1 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.7 | 2.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.7 | 5.4 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.7 | 7.4 | GO:0032039 | integrator complex(GO:0032039) |
0.7 | 0.7 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.7 | 1.3 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.7 | 2.0 | GO:0042585 | germinal vesicle(GO:0042585) |
0.7 | 7.2 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.6 | 5.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.6 | 4.5 | GO:0045179 | apical cortex(GO:0045179) |
0.6 | 1.3 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.6 | 2.6 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.6 | 10.3 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.6 | 3.2 | GO:0044194 | cytolytic granule(GO:0044194) |
0.6 | 13.3 | GO:0051233 | spindle midzone(GO:0051233) |
0.6 | 23.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.6 | 2.5 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.6 | 1.2 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.6 | 18.6 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.6 | 5.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.6 | 121.6 | GO:0000785 | chromatin(GO:0000785) |
0.6 | 5.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.6 | 3.6 | GO:0016342 | catenin complex(GO:0016342) |
0.6 | 1.2 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.6 | 1.8 | GO:0030478 | actin cap(GO:0030478) |
0.6 | 4.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.6 | 0.6 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.6 | 5.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.6 | 20.2 | GO:0045171 | intercellular bridge(GO:0045171) |
0.6 | 2.3 | GO:0045298 | tubulin complex(GO:0045298) |
0.6 | 7.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.6 | 1.7 | GO:0005745 | m-AAA complex(GO:0005745) |
0.6 | 3.3 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.6 | 6.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.6 | 2.2 | GO:0042825 | TAP complex(GO:0042825) |
0.5 | 1.6 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.5 | 2.2 | GO:0034709 | methylosome(GO:0034709) |
0.5 | 14.6 | GO:0005776 | autophagosome(GO:0005776) |
0.5 | 1.6 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.5 | 1.6 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.5 | 5.9 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.5 | 2.7 | GO:0016600 | flotillin complex(GO:0016600) |
0.5 | 1.6 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.5 | 2.7 | GO:0005827 | polar microtubule(GO:0005827) |
0.5 | 0.5 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.5 | 5.3 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.5 | 3.1 | GO:0044327 | dendritic spine head(GO:0044327) |
0.5 | 2.0 | GO:0000322 | storage vacuole(GO:0000322) |
0.5 | 2.0 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.5 | 1.5 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.5 | 0.5 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.5 | 6.9 | GO:0001891 | phagocytic cup(GO:0001891) |
0.5 | 0.5 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.5 | 1.0 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.5 | 0.5 | GO:1990462 | omegasome(GO:1990462) |
0.5 | 1.5 | GO:0030689 | Noc complex(GO:0030689) |
0.5 | 0.5 | GO:0071203 | WASH complex(GO:0071203) |
0.5 | 2.4 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.5 | 2.4 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.5 | 4.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.5 | 8.4 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.5 | 1.9 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.5 | 1.4 | GO:0071942 | XPC complex(GO:0071942) |
0.5 | 0.5 | GO:0070552 | BRISC complex(GO:0070552) |
0.5 | 1.4 | GO:0071010 | prespliceosome(GO:0071010) |
0.5 | 0.9 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.5 | 3.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.5 | 2.3 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.5 | 1.8 | GO:0000796 | condensin complex(GO:0000796) |
0.5 | 10.9 | GO:0012505 | endomembrane system(GO:0012505) |
0.4 | 4.0 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.4 | 0.9 | GO:1990923 | PET complex(GO:1990923) |
0.4 | 5.8 | GO:0034399 | nuclear periphery(GO:0034399) |
0.4 | 1.3 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.4 | 4.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.4 | 5.3 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.4 | 1.3 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.4 | 1.3 | GO:0000811 | GINS complex(GO:0000811) |
0.4 | 5.3 | GO:0000242 | pericentriolar material(GO:0000242) |
0.4 | 1.3 | GO:1990357 | terminal web(GO:1990357) |
0.4 | 3.5 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.4 | 2.6 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.4 | 0.9 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.4 | 1.3 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.4 | 2.5 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.4 | 1.3 | GO:0097452 | GAIT complex(GO:0097452) |
0.4 | 43.1 | GO:0016604 | nuclear body(GO:0016604) |
0.4 | 22.5 | GO:0005643 | nuclear pore(GO:0005643) |
0.4 | 1.2 | GO:0000346 | transcription export complex(GO:0000346) |
0.4 | 2.1 | GO:0045120 | pronucleus(GO:0045120) |
0.4 | 2.5 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.4 | 5.3 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.4 | 0.4 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.4 | 1.2 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.4 | 0.4 | GO:0043601 | nuclear replisome(GO:0043601) |
0.4 | 4.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.4 | 10.4 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.4 | 3.2 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.4 | 2.8 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.4 | 31.1 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.4 | 4.8 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.4 | 2.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.4 | 428.9 | GO:0005654 | nucleoplasm(GO:0005654) |
0.4 | 2.7 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.4 | 1.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.4 | 1.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.4 | 3.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.4 | 5.7 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.4 | 6.1 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.4 | 10.6 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.4 | 3.0 | GO:0051286 | cell tip(GO:0051286) |
0.4 | 2.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.4 | 1.9 | GO:0097422 | tubular endosome(GO:0097422) |
0.4 | 1.1 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.4 | 1.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.4 | 1.5 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.4 | 1.8 | GO:0097542 | ciliary tip(GO:0097542) |
0.4 | 3.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.4 | 2.2 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.4 | 0.7 | GO:0097413 | Lewy body(GO:0097413) |
0.4 | 1.4 | GO:0002177 | manchette(GO:0002177) |
0.4 | 2.5 | GO:0033263 | CORVET complex(GO:0033263) |
0.4 | 0.4 | GO:0071986 | Ragulator complex(GO:0071986) |
0.4 | 2.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.4 | 5.0 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
0.4 | 0.7 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.4 | 1.1 | GO:0042827 | platelet dense granule(GO:0042827) |
0.4 | 3.5 | GO:0046930 | pore complex(GO:0046930) |
0.4 | 3.5 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.3 | 2.1 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.3 | 3.8 | GO:0097440 | apical dendrite(GO:0097440) |
0.3 | 1.7 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.3 | 0.7 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.3 | 1.7 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.3 | 36.4 | GO:0031965 | nuclear membrane(GO:0031965) |
0.3 | 4.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.3 | 3.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.3 | 1.3 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.3 | 0.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.3 | 1.9 | GO:0030904 | retromer complex(GO:0030904) |
0.3 | 0.9 | GO:0098536 | deuterosome(GO:0098536) |
0.3 | 1.2 | GO:1990246 | uniplex complex(GO:1990246) |
0.3 | 0.9 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.3 | 4.0 | GO:0002102 | podosome(GO:0002102) |
0.3 | 0.3 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.3 | 12.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.3 | 0.6 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.3 | 2.7 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 1.8 | GO:1902554 | serine/threonine protein kinase complex(GO:1902554) |
0.3 | 2.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.3 | 110.3 | GO:0005730 | nucleolus(GO:0005730) |
0.3 | 2.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.3 | 1.8 | GO:0032009 | early phagosome(GO:0032009) |
0.3 | 26.8 | GO:0072562 | blood microparticle(GO:0072562) |
0.3 | 0.9 | GO:0043293 | apoptosome(GO:0043293) |
0.3 | 4.4 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.3 | 1.4 | GO:0031143 | pseudopodium(GO:0031143) |
0.3 | 10.4 | GO:0031228 | integral component of Golgi membrane(GO:0030173) intrinsic component of Golgi membrane(GO:0031228) |
0.3 | 5.6 | GO:0001772 | immunological synapse(GO:0001772) |
0.3 | 1.9 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.3 | 3.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.3 | 1.4 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.3 | 2.4 | GO:0005876 | spindle microtubule(GO:0005876) |
0.3 | 11.2 | GO:0005811 | lipid particle(GO:0005811) |
0.3 | 9.4 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.3 | 0.8 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.3 | 4.9 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.3 | 1.3 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.3 | 0.8 | GO:1990391 | DNA repair complex(GO:1990391) |
0.3 | 0.8 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.3 | 0.5 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.3 | 0.5 | GO:0030897 | HOPS complex(GO:0030897) |
0.2 | 1.5 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 8.7 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 1.7 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 5.4 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.2 | 0.7 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.2 | 0.5 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.2 | 2.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 2.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 2.3 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 0.9 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.2 | 0.7 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.2 | 0.7 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.2 | 0.2 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.2 | 11.9 | GO:0055037 | recycling endosome(GO:0055037) |
0.2 | 1.7 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.2 | 3.0 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.2 | 1.5 | GO:0005657 | replication fork(GO:0005657) |
0.2 | 5.2 | GO:0005795 | Golgi stack(GO:0005795) |
0.2 | 0.6 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 10.1 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.2 | 0.8 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 0.8 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.2 | 1.5 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 10.2 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.2 | 1.0 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 0.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 0.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.2 | 4.0 | GO:0030286 | dynein complex(GO:0030286) |
0.2 | 16.2 | GO:0005694 | chromosome(GO:0005694) |
0.2 | 0.6 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 0.6 | GO:0097443 | sorting endosome(GO:0097443) |
0.2 | 0.6 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.2 | 1.9 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.2 | 1.1 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.2 | 5.3 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.2 | 0.4 | GO:0032797 | SMN complex(GO:0032797) |
0.2 | 0.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 0.4 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.2 | 0.5 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.2 | 0.9 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 3.5 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.2 | 0.2 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.2 | 0.7 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.2 | 1.6 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 2.7 | GO:0043034 | costamere(GO:0043034) |
0.2 | 2.5 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.2 | 1.3 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.2 | 12.2 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.2 | 10.6 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.2 | 7.2 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.2 | 2.8 | GO:0030496 | midbody(GO:0030496) |
0.2 | 0.3 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 7.0 | GO:0043231 | intracellular membrane-bounded organelle(GO:0043231) |
0.2 | 0.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 0.5 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 0.5 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.2 | 24.2 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.2 | 10.9 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.2 | 0.6 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 409.6 | GO:0005634 | nucleus(GO:0005634) |
0.2 | 0.6 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 31.3 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 0.3 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 0.3 | GO:0061695 | transferase complex, transferring phosphorus-containing groups(GO:0061695) |
0.1 | 5.8 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 3.8 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.1 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.1 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
0.1 | 0.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.4 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 2.4 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 0.8 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.5 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.7 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 1.5 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 4.2 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 64.0 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 14.8 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.1 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.2 | GO:0033655 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
0.1 | 0.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 11.6 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.1 | 0.4 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 8.2 | GO:0005874 | microtubule(GO:0005874) |
0.1 | 0.5 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 1.2 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.1 | 0.1 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 0.4 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 2.0 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.1 | 0.3 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.5 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.1 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 1.3 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 0.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 21.2 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 26.5 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 0.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.1 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 0.1 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.0 | 0.0 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.0 | 0.0 | GO:0044292 | dendrite terminus(GO:0044292) |
0.0 | 0.0 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.0 | GO:0005840 | ribosome(GO:0005840) |
0.0 | 0.9 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.1 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.0 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.0 | 0.0 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.1 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.1 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.1 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.0 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.0 | 0.5 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 36.4 | GO:0005737 | cytoplasm(GO:0005737) |
0.0 | 0.4 | GO:0099512 | supramolecular fiber(GO:0099512) polymeric cytoskeletal fiber(GO:0099513) |
0.0 | 0.0 | GO:0043218 | compact myelin(GO:0043218) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.9 | 19.6 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
3.9 | 11.8 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
3.7 | 14.7 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
3.5 | 28.3 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
3.1 | 12.5 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
3.0 | 9.0 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
2.8 | 8.5 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
2.8 | 8.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
2.7 | 10.9 | GO:0070878 | primary miRNA binding(GO:0070878) |
2.6 | 7.8 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
2.5 | 12.6 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
2.3 | 6.9 | GO:1990188 | euchromatin binding(GO:1990188) |
2.3 | 6.8 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
2.2 | 6.6 | GO:0016361 | activin receptor activity, type I(GO:0016361) activin-activated receptor activity(GO:0017002) |
2.0 | 8.2 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
2.0 | 10.1 | GO:1990239 | steroid hormone binding(GO:1990239) |
2.0 | 6.0 | GO:0050692 | DBD domain binding(GO:0050692) |
1.9 | 5.8 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.9 | 5.7 | GO:0097016 | L27 domain binding(GO:0097016) |
1.9 | 18.9 | GO:0070410 | co-SMAD binding(GO:0070410) |
1.9 | 5.6 | GO:0005119 | smoothened binding(GO:0005119) |
1.9 | 7.4 | GO:0036033 | mediator complex binding(GO:0036033) |
1.9 | 5.6 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
1.9 | 5.6 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.8 | 9.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
1.8 | 5.4 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
1.8 | 1.8 | GO:0050693 | LBD domain binding(GO:0050693) |
1.8 | 1.8 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
1.8 | 12.5 | GO:0034046 | poly(G) binding(GO:0034046) |
1.7 | 5.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.6 | 6.6 | GO:0098821 | BMP receptor activity(GO:0098821) |
1.6 | 21.3 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
1.6 | 8.0 | GO:0030957 | Tat protein binding(GO:0030957) |
1.6 | 17.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
1.6 | 7.8 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
1.6 | 12.5 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
1.5 | 6.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
1.5 | 3.0 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
1.5 | 7.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
1.5 | 5.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.4 | 4.3 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
1.4 | 4.2 | GO:0004359 | glutaminase activity(GO:0004359) |
1.4 | 6.8 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
1.4 | 5.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
1.4 | 4.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
1.3 | 9.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
1.3 | 6.7 | GO:0043426 | MRF binding(GO:0043426) |
1.3 | 11.9 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
1.3 | 15.6 | GO:0008432 | JUN kinase binding(GO:0008432) |
1.3 | 5.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
1.3 | 5.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.3 | 2.6 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
1.3 | 7.7 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
1.3 | 10.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
1.3 | 20.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
1.3 | 3.8 | GO:0009041 | uridylate kinase activity(GO:0009041) |
1.2 | 2.5 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
1.2 | 12.4 | GO:0048156 | tau protein binding(GO:0048156) |
1.2 | 24.6 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
1.2 | 8.6 | GO:0035197 | siRNA binding(GO:0035197) |
1.2 | 14.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
1.2 | 13.3 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
1.2 | 7.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
1.2 | 15.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
1.2 | 4.8 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.2 | 1.2 | GO:0035174 | histone serine kinase activity(GO:0035174) histone kinase activity (H3-S10 specific)(GO:0035175) |
1.2 | 4.7 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
1.2 | 1.2 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
1.2 | 8.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
1.1 | 12.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
1.1 | 4.6 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.1 | 34.7 | GO:0031491 | nucleosome binding(GO:0031491) |
1.1 | 11.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
1.1 | 7.7 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
1.1 | 3.3 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
1.1 | 3.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
1.1 | 1.1 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
1.1 | 5.4 | GO:0070728 | leucine binding(GO:0070728) |
1.1 | 8.6 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
1.1 | 8.5 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
1.0 | 1.0 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
1.0 | 3.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
1.0 | 3.1 | GO:0008142 | oxysterol binding(GO:0008142) |
1.0 | 2.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
1.0 | 4.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.0 | 20.6 | GO:0042162 | telomeric DNA binding(GO:0042162) |
1.0 | 1.0 | GO:0003696 | satellite DNA binding(GO:0003696) |
1.0 | 30.5 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
1.0 | 4.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
1.0 | 3.0 | GO:0050815 | phosphoserine binding(GO:0050815) |
1.0 | 3.0 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
1.0 | 9.1 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
1.0 | 4.0 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
1.0 | 16.9 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
1.0 | 6.0 | GO:0000182 | rDNA binding(GO:0000182) |
1.0 | 13.9 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
1.0 | 19.9 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
1.0 | 1.0 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
1.0 | 2.9 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.0 | 6.7 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.0 | 1.9 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.9 | 2.8 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.9 | 8.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.9 | 10.3 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.9 | 6.5 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.9 | 2.8 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.9 | 4.6 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.9 | 12.7 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.9 | 4.5 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.9 | 2.7 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.9 | 8.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.9 | 1.8 | GO:0030519 | snoRNP binding(GO:0030519) |
0.9 | 2.7 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.9 | 4.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.9 | 2.7 | GO:0019002 | GMP binding(GO:0019002) |
0.9 | 1.8 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.9 | 29.1 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.9 | 5.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.9 | 7.0 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.9 | 2.6 | GO:0030911 | TPR domain binding(GO:0030911) |
0.9 | 20.6 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.9 | 3.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.8 | 2.5 | GO:0032564 | dATP binding(GO:0032564) |
0.8 | 5.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.8 | 5.0 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.8 | 4.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.8 | 9.1 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.8 | 6.6 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.8 | 0.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.8 | 32.5 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.8 | 3.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.8 | 23.3 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.8 | 0.8 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) |
0.8 | 5.6 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.8 | 3.2 | GO:0009374 | biotin binding(GO:0009374) |
0.8 | 0.8 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.8 | 0.8 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.8 | 3.9 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.8 | 0.8 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.8 | 2.3 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.8 | 7.7 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.8 | 1.5 | GO:0043398 | HLH domain binding(GO:0043398) |
0.8 | 29.9 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.8 | 7.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.8 | 15.2 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.8 | 2.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.8 | 2.3 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.8 | 2.3 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.8 | 0.8 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.7 | 7.5 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.7 | 0.7 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.7 | 9.7 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.7 | 3.0 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.7 | 2.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.7 | 3.7 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.7 | 2.2 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.7 | 2.9 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.7 | 5.9 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.7 | 4.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.7 | 0.7 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.7 | 2.9 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.7 | 23.6 | GO:0035064 | methylated histone binding(GO:0035064) |
0.7 | 19.1 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.7 | 86.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.7 | 0.7 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.7 | 5.6 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.7 | 2.8 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.7 | 2.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.7 | 2.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.7 | 0.7 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.7 | 12.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.7 | 14.3 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.7 | 0.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.7 | 4.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.7 | 16.4 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.7 | 2.7 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.7 | 9.2 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.7 | 2.0 | GO:0019961 | interferon binding(GO:0019961) |
0.7 | 11.2 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.7 | 7.2 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.7 | 3.9 | GO:0030274 | LIM domain binding(GO:0030274) |
0.7 | 10.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.7 | 8.5 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.6 | 9.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.6 | 5.8 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.6 | 0.6 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.6 | 89.3 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.6 | 2.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.6 | 14.0 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.6 | 1.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.6 | 3.8 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.6 | 9.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.6 | 3.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.6 | 3.1 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.6 | 3.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.6 | 3.7 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.6 | 5.6 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.6 | 4.3 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.6 | 1.8 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.6 | 22.0 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.6 | 2.4 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.6 | 0.6 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.6 | 2.4 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.6 | 3.6 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.6 | 16.8 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.6 | 3.0 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.6 | 0.6 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.6 | 1.2 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.6 | 5.8 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.6 | 0.6 | GO:0038191 | neuropilin binding(GO:0038191) |
0.6 | 2.9 | GO:0043559 | insulin binding(GO:0043559) |
0.6 | 2.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.6 | 2.9 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.6 | 2.9 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.6 | 10.8 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.6 | 1.1 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.6 | 5.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.6 | 2.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.6 | 1.7 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.6 | 3.4 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.6 | 4.4 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.6 | 1.7 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.5 | 15.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.5 | 11.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.5 | 0.5 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.5 | 1.6 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.5 | 1.6 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.5 | 2.7 | GO:0008494 | translation activator activity(GO:0008494) |
0.5 | 1.6 | GO:0030984 | kininogen binding(GO:0030984) |
0.5 | 1.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.5 | 5.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.5 | 0.5 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.5 | 1.0 | GO:0051425 | PTB domain binding(GO:0051425) |
0.5 | 1.0 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.5 | 9.8 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.5 | 1.5 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.5 | 4.6 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.5 | 1.5 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.5 | 3.1 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.5 | 17.3 | GO:0035326 | enhancer binding(GO:0035326) |
0.5 | 1.5 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.5 | 9.6 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.5 | 0.5 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.5 | 2.0 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.5 | 1.5 | GO:0034452 | dynactin binding(GO:0034452) |
0.5 | 2.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.5 | 2.0 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.5 | 11.8 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.5 | 1.5 | GO:0055100 | adiponectin binding(GO:0055100) |
0.5 | 1.5 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.5 | 1.0 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.5 | 1.5 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.5 | 1.5 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.5 | 1.4 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.5 | 24.0 | GO:0019003 | GDP binding(GO:0019003) |
0.5 | 1.4 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.5 | 0.9 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.5 | 10.8 | GO:0043531 | ADP binding(GO:0043531) |
0.5 | 6.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.5 | 4.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.5 | 0.9 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.5 | 0.5 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.5 | 4.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.5 | 1.4 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.5 | 2.8 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.5 | 1.4 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.5 | 10.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.5 | 1.8 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.5 | 1.8 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.5 | 1.4 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.5 | 0.5 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.4 | 0.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.4 | 2.7 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.4 | 1.8 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.4 | 7.1 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.4 | 13.6 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.4 | 3.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.4 | 1.3 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.4 | 1.3 | GO:0071253 | connexin binding(GO:0071253) |
0.4 | 0.9 | GO:0089720 | caspase binding(GO:0089720) |
0.4 | 4.8 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.4 | 2.2 | GO:0038132 | neuregulin binding(GO:0038132) |
0.4 | 2.2 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.4 | 2.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.4 | 7.8 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.4 | 5.2 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.4 | 3.9 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.4 | 2.6 | GO:0050733 | RS domain binding(GO:0050733) |
0.4 | 21.5 | GO:0042393 | histone binding(GO:0042393) |
0.4 | 1.7 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.4 | 0.9 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.4 | 1.7 | GO:0032183 | SUMO binding(GO:0032183) |
0.4 | 3.0 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.4 | 12.0 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.4 | 1.7 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.4 | 3.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.4 | 0.4 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.4 | 2.5 | GO:0004064 | arylesterase activity(GO:0004064) |
0.4 | 1.3 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.4 | 3.4 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.4 | 4.7 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.4 | 2.1 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.4 | 1.7 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.4 | 2.5 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.4 | 17.2 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.4 | 14.3 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.4 | 8.0 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.4 | 1.3 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.4 | 1.7 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.4 | 11.7 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.4 | 0.4 | GO:0034618 | arginine binding(GO:0034618) |
0.4 | 6.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.4 | 2.5 | GO:0015288 | porin activity(GO:0015288) |
0.4 | 0.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.4 | 9.9 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.4 | 1.6 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.4 | 10.6 | GO:0001047 | core promoter binding(GO:0001047) |
0.4 | 2.4 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.4 | 2.8 | GO:0045545 | syndecan binding(GO:0045545) |
0.4 | 2.8 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.4 | 0.4 | GO:0030580 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
0.4 | 1.2 | GO:0035198 | miRNA binding(GO:0035198) |
0.4 | 1.6 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.4 | 1.6 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.4 | 0.4 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.4 | 1.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.4 | 0.8 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.4 | 1.2 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.4 | 20.6 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.4 | 2.0 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.4 | 1.2 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.4 | 0.8 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.4 | 2.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.4 | 10.9 | GO:0030507 | spectrin binding(GO:0030507) |
0.4 | 2.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.4 | 1.6 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.4 | 0.8 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.4 | 0.4 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.4 | 2.3 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.4 | 5.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.4 | 2.7 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.4 | 1.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.4 | 1.1 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.4 | 19.6 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.4 | 9.4 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.4 | 0.4 | GO:0016896 | 3'-5'-exoribonuclease activity(GO:0000175) exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.4 | 1.1 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.4 | 6.3 | GO:0043022 | ribosome binding(GO:0043022) |
0.4 | 4.4 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.4 | 59.8 | GO:0003682 | chromatin binding(GO:0003682) |
0.4 | 0.7 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.4 | 4.0 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.4 | 6.6 | GO:0045502 | dynein binding(GO:0045502) |
0.4 | 1.8 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.4 | 1.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.4 | 1.4 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.4 | 2.9 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.4 | 21.5 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.4 | 1.1 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.4 | 1.1 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.4 | 0.4 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.4 | 0.7 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.4 | 0.7 | GO:0016428 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.3 | 0.3 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.3 | 2.4 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.3 | 1.4 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.3 | 1.7 | GO:0005113 | patched binding(GO:0005113) |
0.3 | 0.7 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.3 | 0.7 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.3 | 1.0 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.3 | 0.7 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.3 | 3.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 8.6 | GO:0016419 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.3 | 3.1 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.3 | 0.7 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.3 | 0.3 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.3 | 0.7 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.3 | 1.0 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.3 | 4.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.3 | 6.1 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.3 | 3.7 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.3 | 1.7 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.3 | 1.0 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.3 | 8.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.3 | 2.7 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.3 | 0.7 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.3 | 1.0 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.3 | 1.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.3 | 0.7 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.3 | 2.0 | GO:0031419 | cobalamin binding(GO:0031419) |
0.3 | 20.7 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.3 | 0.7 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.3 | 0.7 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.3 | 1.3 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.3 | 1.6 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.3 | 0.6 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.3 | 5.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.3 | 1.6 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.3 | 1.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.3 | 0.3 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.3 | 3.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.3 | 1.3 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.3 | 1.9 | GO:0031996 | thioesterase binding(GO:0031996) |
0.3 | 7.3 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.3 | 28.7 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.3 | 3.8 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 4.1 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.3 | 0.3 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.3 | 0.6 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.3 | 0.9 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.3 | 0.9 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.3 | 3.4 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.3 | 1.9 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.3 | 0.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.3 | 3.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.3 | 0.6 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.3 | 3.6 | GO:0001618 | virus receptor activity(GO:0001618) |
0.3 | 5.4 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.3 | 214.5 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.3 | 0.9 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.3 | 1.2 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.3 | 2.9 | GO:0034946 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.3 | 1.1 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.3 | 1.4 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.3 | 3.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.3 | 1.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.3 | 0.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.3 | 1.4 | GO:0017040 | ceramidase activity(GO:0017040) |
0.3 | 2.8 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.3 | 0.8 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.3 | 4.8 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.3 | 2.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.3 | 1.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.3 | 0.5 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.3 | 0.8 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.3 | 1.4 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.3 | 1.6 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.3 | 0.5 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.3 | 2.7 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.3 | 0.5 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.3 | 21.7 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.3 | 0.5 | GO:0016151 | nickel cation binding(GO:0016151) |
0.3 | 5.2 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.3 | 0.5 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.3 | 1.0 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.3 | 4.1 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.3 | 0.3 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.3 | 1.0 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.3 | 1.5 | GO:0019209 | kinase activator activity(GO:0019209) |
0.3 | 7.9 | GO:0044824 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.3 | 1.0 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
0.3 | 2.0 | GO:0005521 | lamin binding(GO:0005521) |
0.3 | 0.5 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.3 | 0.3 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.3 | 0.8 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.2 | 1.7 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 1.7 | GO:0030515 | snoRNA binding(GO:0030515) |
0.2 | 1.0 | GO:0019808 | polyamine binding(GO:0019808) |
0.2 | 3.9 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.2 | 0.2 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.2 | 1.0 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.2 | 0.7 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 0.2 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.2 | 0.2 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.2 | 0.9 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 0.7 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 7.7 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 0.7 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.2 | 1.4 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.2 | 3.9 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.2 | 40.2 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.2 | 1.1 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.2 | 0.7 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.2 | 0.5 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.2 | 9.0 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.2 | 0.7 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.2 | 0.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.2 | 1.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 2.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 0.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 0.6 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.2 | 0.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 0.2 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.2 | 1.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 0.9 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.2 | 0.2 | GO:0030523 | dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.2 | 1.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.2 | 2.5 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.2 | 0.6 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.2 | 0.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 4.2 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.2 | 0.2 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.2 | 0.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 1.0 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.2 | 0.8 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 0.4 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.2 | 0.2 | GO:0035877 | death effector domain binding(GO:0035877) |
0.2 | 1.2 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.2 | 0.2 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.2 | 4.4 | GO:0000049 | tRNA binding(GO:0000049) |
0.2 | 0.2 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.2 | 0.2 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.2 | 0.4 | GO:0035473 | lipase binding(GO:0035473) |
0.2 | 0.4 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 0.6 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.2 | 0.4 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.2 | 0.6 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 1.5 | GO:0018748 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.2 | 1.5 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.2 | 0.6 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.2 | 0.9 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.2 | 18.5 | GO:0003924 | GTPase activity(GO:0003924) |
0.2 | 0.9 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 5.9 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.2 | 5.5 | GO:0008134 | transcription factor binding(GO:0008134) |
0.2 | 3.4 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.2 | 0.4 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.2 | 0.7 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.2 | 19.8 | GO:0005525 | GTP binding(GO:0005525) |
0.2 | 0.2 | GO:0042805 | actinin binding(GO:0042805) |
0.2 | 0.5 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.2 | 2.0 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.2 | 0.9 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.2 | 0.9 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 0.2 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.2 | 0.7 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 0.5 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.2 | 0.5 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 0.9 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 1.0 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.2 | 0.3 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.2 | 0.5 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.2 | 0.8 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 0.7 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.2 | 1.3 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.2 | 0.5 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.2 | 5.0 | GO:0018731 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) 3,4-dihydrocoumarin hydrolase activity(GO:0018733) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.2 | 1.3 | GO:0034918 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.2 | 0.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.2 | 0.3 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.2 | 1.0 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.2 | 2.3 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.2 | 1.1 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.2 | 0.8 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.2 | 2.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 0.2 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.2 | 0.5 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.2 | 0.6 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.2 | 0.2 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.2 | 6.4 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.2 | 2.0 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 0.9 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 0.8 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.2 | 0.3 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) peptide transmembrane transporter activity(GO:1904680) |
0.2 | 0.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.2 | 6.7 | GO:0008565 | protein transporter activity(GO:0008565) |
0.2 | 0.8 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.2 | 0.5 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 0.4 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) |
0.1 | 0.6 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 0.9 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.3 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 0.1 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.1 | 0.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.4 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.9 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 3.8 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 1.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 1.9 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 0.9 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.1 | GO:0036222 | XTP diphosphatase activity(GO:0036222) |
0.1 | 0.1 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.1 | 0.1 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.1 | 0.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 1.0 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 0.8 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 1.2 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 4.7 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 10.5 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 2.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.8 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.9 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.1 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.1 | 0.3 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 4.1 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.1 | 0.3 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.1 | 1.5 | GO:0019239 | deaminase activity(GO:0019239) |
0.1 | 1.0 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.1 | 0.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 20.8 | GO:0003723 | RNA binding(GO:0003723) |
0.1 | 7.0 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 1.8 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 0.4 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.1 | GO:0070061 | fructose binding(GO:0070061) |
0.1 | 0.5 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 1.2 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.1 | 0.7 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 1.3 | GO:0016875 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 0.7 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 0.4 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 6.7 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 0.7 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 0.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 2.3 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.5 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 4.8 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 6.0 | GO:0016887 | ATPase activity(GO:0016887) |
0.1 | 1.2 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 8.7 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.4 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.1 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 0.6 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.6 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.2 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.1 | 2.3 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 0.2 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.4 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 2.7 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.1 | 0.4 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 0.5 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.4 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.1 | 0.6 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.1 | 0.5 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 0.9 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 0.7 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.1 | 1.6 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.1 | 11.4 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.1 | 0.1 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.1 | 81.3 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.1 | 1.7 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.8 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 2.0 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.1 | 0.1 | GO:0060229 | lipase activator activity(GO:0060229) lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.7 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.9 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 2.5 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 0.8 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 3.0 | GO:0000988 | transcription factor activity, protein binding(GO:0000988) |
0.1 | 1.9 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.4 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) peptidoglycan binding(GO:0042834) |
0.1 | 0.3 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.1 | 0.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.2 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 0.1 | GO:0017111 | nucleoside-triphosphatase activity(GO:0017111) |
0.1 | 0.2 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.2 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 0.2 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.1 | 0.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.8 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.1 | 0.6 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.2 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 0.9 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.2 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.6 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.4 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.2 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.1 | 0.3 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.1 | 0.2 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.4 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 1.4 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 1.1 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 2.6 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.1 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 0.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 2.9 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
0.1 | 0.1 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.1 | 0.1 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
0.1 | 0.3 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 0.4 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 0.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 0.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.6 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.1 | 3.3 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.1 | 1.7 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.2 | GO:1901567 | icosanoid binding(GO:0050542) icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.1 | 0.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.2 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.1 | 0.2 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 0.1 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 0.2 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.1 | 1.5 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.1 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.1 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.1 | 1.5 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.2 | GO:0055102 | phospholipase inhibitor activity(GO:0004859) lipase inhibitor activity(GO:0055102) |
0.1 | 0.1 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.1 | 0.8 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.1 | 0.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 0.5 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 1.2 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.4 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.0 | 0.5 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 1.2 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.0 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.0 | 0.4 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.0 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.2 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.0 | 0.4 | GO:0032451 | demethylase activity(GO:0032451) |
0.0 | 0.1 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.0 | 0.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.0 | 0.4 | GO:0043734 | DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.0 | 0.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.7 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 1.0 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 5.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.9 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 0.0 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 1.7 | GO:0005496 | steroid binding(GO:0005496) |
0.0 | 0.0 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 1.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.0 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.0 | 0.2 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.0 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.1 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
0.0 | 8.0 | GO:0008270 | zinc ion binding(GO:0008270) |
0.0 | 0.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.0 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.0 | 0.0 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.0 | 0.4 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.8 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.0 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.0 | 0.1 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.0 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.0 | 0.0 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.0 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.0 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.0 | 0.1 | GO:0090484 | drug transporter activity(GO:0090484) |
0.0 | 0.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.1 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.2 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.0 | 0.2 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 0.1 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.4 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.0 | 0.0 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.4 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.1 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.0 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.1 | GO:0004518 | nuclease activity(GO:0004518) |
0.0 | 0.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 1.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.0 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.0 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.0 | 0.1 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.0 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 6.5 | PID ERBB4 PATHWAY | ErbB4 signaling events |
2.0 | 34.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
1.5 | 74.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
1.5 | 45.5 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
1.4 | 12.7 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
1.4 | 28.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
1.3 | 62.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
1.2 | 17.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
1.2 | 14.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
1.2 | 21.6 | PID MYC PATHWAY | C-MYC pathway |
1.2 | 20.1 | PID IGF1 PATHWAY | IGF1 pathway |
1.1 | 8.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
1.1 | 10.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
1.1 | 28.0 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
1.1 | 29.0 | PID IFNG PATHWAY | IFN-gamma pathway |
1.1 | 6.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
1.0 | 22.6 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
1.0 | 41.0 | PID P53 REGULATION PATHWAY | p53 pathway |
1.0 | 6.9 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.0 | 1.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.9 | 1.8 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.9 | 10.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.9 | 28.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.9 | 34.6 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.9 | 18.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.9 | 3.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.9 | 10.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.9 | 23.4 | PID RHOA PATHWAY | RhoA signaling pathway |
0.8 | 23.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.8 | 6.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.8 | 9.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.8 | 7.0 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.7 | 26.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.7 | 7.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.7 | 13.9 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.7 | 31.4 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.7 | 9.8 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.6 | 2.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.6 | 7.4 | PID ARF 3PATHWAY | Arf1 pathway |
0.6 | 4.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.6 | 16.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.6 | 7.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.6 | 3.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.6 | 16.6 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.5 | 9.3 | PID CDC42 PATHWAY | CDC42 signaling events |
0.5 | 12.6 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.5 | 7.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.5 | 11.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.5 | 15.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.5 | 3.6 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.5 | 5.6 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.5 | 6.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.5 | 1.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.5 | 6.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.5 | 2.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.5 | 6.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.5 | 8.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.5 | 6.7 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.5 | 14.8 | PID PLK1 PATHWAY | PLK1 signaling events |
0.5 | 6.6 | PID INSULIN PATHWAY | Insulin Pathway |
0.5 | 3.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.5 | 9.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.5 | 12.0 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.5 | 20.4 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.4 | 11.0 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.4 | 10.5 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.4 | 1.3 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.4 | 2.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.4 | 5.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.4 | 7.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.4 | 0.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.4 | 0.8 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.4 | 0.7 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.4 | 11.3 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.4 | 5.8 | PID RAS PATHWAY | Regulation of Ras family activation |
0.4 | 0.7 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.4 | 10.5 | PID E2F PATHWAY | E2F transcription factor network |
0.4 | 7.0 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.3 | 5.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.3 | 1.4 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.3 | 9.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.3 | 2.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.3 | 0.6 | ST GAQ PATHWAY | G alpha q Pathway |
0.3 | 16.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.3 | 1.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.3 | 2.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 3.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.3 | 1.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.3 | 3.0 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.3 | 1.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 7.3 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.3 | 3.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.3 | 1.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 1.2 | PID BARD1 PATHWAY | BARD1 signaling events |
0.2 | 2.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 1.0 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 1.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 3.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 1.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 0.9 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.2 | 0.4 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 1.5 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 4.2 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 6.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 1.4 | PID ATM PATHWAY | ATM pathway |
0.2 | 1.8 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 2.1 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 3.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 0.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 1.1 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 0.2 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 2.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 1.1 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 0.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 1.5 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 2.4 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 0.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.6 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 0.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 1.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 2.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 0.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 1.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 1.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 2.0 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 0.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 0.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.4 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.2 | 25.9 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
2.6 | 20.7 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
2.1 | 12.8 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
2.1 | 2.1 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
2.1 | 39.3 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
1.8 | 3.6 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
1.7 | 25.8 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
1.7 | 1.7 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
1.5 | 13.7 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
1.5 | 6.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
1.5 | 1.5 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
1.4 | 8.6 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
1.4 | 20.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.4 | 24.6 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
1.3 | 1.3 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
1.3 | 18.7 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
1.3 | 45.3 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
1.3 | 19.9 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
1.2 | 11.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
1.2 | 37.1 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
1.2 | 18.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
1.2 | 20.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
1.2 | 17.4 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
1.2 | 11.6 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
1.1 | 26.9 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
1.1 | 16.8 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
1.1 | 21.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
1.1 | 18.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
1.1 | 12.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
1.1 | 14.7 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
1.0 | 4.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.0 | 7.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
1.0 | 8.0 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
1.0 | 23.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
1.0 | 18.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
1.0 | 6.8 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
1.0 | 1.9 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.9 | 16.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.9 | 6.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.9 | 8.0 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.9 | 2.6 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.8 | 6.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.8 | 12.6 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.8 | 9.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.8 | 5.0 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.8 | 4.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.8 | 4.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.8 | 2.4 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.8 | 0.8 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.8 | 17.9 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.8 | 9.7 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.7 | 35.7 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.7 | 3.0 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.7 | 5.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.7 | 41.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.7 | 10.1 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.7 | 28.1 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.7 | 2.0 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.7 | 10.5 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.7 | 3.3 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.6 | 17.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.6 | 7.0 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.6 | 1.3 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.6 | 5.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.6 | 4.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.6 | 7.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.6 | 15.8 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.6 | 2.8 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.6 | 2.8 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.6 | 4.5 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.6 | 8.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.5 | 13.2 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.5 | 3.8 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.5 | 7.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.5 | 12.0 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.5 | 1.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.5 | 2.1 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.5 | 8.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.5 | 1.0 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.5 | 7.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.5 | 5.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.5 | 1.5 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.5 | 6.5 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.5 | 34.7 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.5 | 6.4 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.5 | 2.4 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.5 | 6.2 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.5 | 4.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.5 | 7.0 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.5 | 3.7 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.5 | 3.2 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.4 | 6.7 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.4 | 6.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.4 | 15.3 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.4 | 3.5 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.4 | 3.8 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.4 | 3.4 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.4 | 6.7 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.4 | 5.9 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.4 | 15.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.4 | 67.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.4 | 5.0 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.4 | 3.3 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.4 | 8.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.4 | 10.7 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.4 | 2.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.4 | 13.3 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.4 | 6.6 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.4 | 2.3 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.4 | 2.3 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.4 | 4.5 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.4 | 1.9 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.4 | 5.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.4 | 0.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.4 | 6.0 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.4 | 1.8 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.4 | 3.9 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.3 | 9.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 2.7 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.3 | 5.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 4.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.3 | 6.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.3 | 2.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.3 | 6.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.3 | 11.3 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.3 | 26.2 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.3 | 1.2 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.3 | 2.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.3 | 3.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.3 | 5.8 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.3 | 3.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.3 | 14.9 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.3 | 21.0 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.3 | 2.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.3 | 4.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.3 | 3.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.3 | 3.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.3 | 2.7 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.3 | 2.7 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.3 | 5.2 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.3 | 0.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.3 | 1.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.3 | 1.0 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.3 | 0.5 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.3 | 1.8 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.2 | 1.5 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.2 | 2.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.2 | 4.7 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 8.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 0.2 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.2 | 2.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 1.2 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.2 | 2.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 2.3 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 0.2 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.2 | 6.2 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 2.0 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 0.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 0.5 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.2 | 7.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 3.5 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.2 | 4.2 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.2 | 2.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.2 | 4.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 0.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.2 | 1.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 0.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 4.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 0.2 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.2 | 6.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 2.1 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 2.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.2 | 1.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 0.7 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.2 | 8.4 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 2.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 9.4 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.2 | 0.2 | REACTOME G1 S TRANSITION | Genes involved in G1/S Transition |
0.2 | 2.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 0.2 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.2 | 0.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 1.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 1.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 0.2 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.2 | 0.6 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 1.2 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 2.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 1.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 1.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.3 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 3.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 1.3 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.1 | 0.1 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 2.1 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.1 | 2.9 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 0.5 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 3.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 1.5 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 2.0 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 1.7 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.1 | 1.5 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 0.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 1.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 4.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 1.3 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 1.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 1.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.4 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.1 | 0.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 1.0 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 0.1 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 0.1 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 1.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 1.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.7 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 4.2 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 0.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 0.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 0.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 0.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 0.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 1.0 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 3.3 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 0.4 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.1 | 0.8 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 1.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.2 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.3 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.0 | 0.3 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 2.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.8 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.1 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.0 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.0 | 0.0 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.0 | 0.1 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.0 | 0.3 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.0 | 0.1 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.1 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |